Marshall University

Marshall Digital Scholar
Theses, Dissertations and Capstones
2021

Role of Na/K-ATPase Non-enzymatic Signaling in Renal Proximal
Tubule Sodium Transport
Shreya Tapan Mukherji

Follow this and additional works at: https://mds.marshall.edu/etd
Part of the Endocrinology Commons, Medical Molecular Biology Commons, and the Molecular
Genetics Commons

ROLE OF NA/K-ATPASE NON-ENZYMATIC SIGNALING IN RENAL PROXIMAL
TUBULE SODIUM TRANSPORT

A dissertation submitted to
the Graduate College of
Marshall University
In partial fulfillment of
the requirements for the degree of
Doctor of Philosophy
In
Biomedical Research
by
Shreya Tapan Mukherji
Approved by
Dr. Sandrine Pierre, Committee Chairperson
Dr. Joseph Shapiro
Dr. Jiang Liu
Dr. Gustavo Blanco
Dr. Jiang Tian

Marshall University
July 2021

APPROVAL OF THESIS

ii

© 2021
Shreya Tapan Mukherji
ALL RIGHTS RESERVED
iii

DEDICATION
This dissertation is dedicated to my advisor, the late Dr. Zijian Xie. I was extremely fortunate to
have had a brilliant scientist, a pioneer, and a compassionate person like him as a mentor and I
wish he were still here with us. I would also like to dedicate this dissertation to my parents and
my sister- they have always been the wind beneath my wings.

iv

ACKNOWLEDGEMENTS

I would like to first and foremost thank my PhD advisors. Any PhD student is happy to have one
great mentor, but I was so fortunate to have two. The late Dr. Zijian Xie, whose vision laid the
groundwork for this research project, only ever had words of motivation and encouragement for
me. His enthusiasm for science and research was inspirational, and I am deeply saddened that he
is not here with us anymore. Dr. Sandrine Pierre has always had her doors open for me and her
help and guidance have defined my path in scientific research. She has been a wonderful mentor
and her support and encouragement have been a phenomenal driving force in my PhD training.
She inspires me not just as a scientist but as a strong advocate for all women in science. Next, I
would like to thank all my eminent and distinguished committee members- Dr. Joseph Shapiro,
Dr. Gustavo Blanco, Dr. Jiang Liu, and Dr. Jiang Tian for agreeing to serve on my committee,
their valuable feedback and critique, and their constant support and motivation.
I would have been lost and unmoored without the anchoring provided by my family and friends.
Going through the final year of PhD in the middle of a pandemic is a challenge no one can
prepare for and I am so grateful to my phenomenal support system for keeping me afloat. My
parents, Tapan and Anindita Mukherji, and my sister, Anjali Satoskar, are my ultimate
cheerleaders and I am fortunate to be on the receiving end of their boundless love.
I would like to thank Dr. Laura Kutz who has been a wonderful friend and an amazing coworker.
She and her family have always been there for me and provided me a home away from home.
Friends are the family you choose and I have found a family in my fabulous pizzazz group.
Vega, Gayatri, Sahil, Siddhesh, Ishan, and Abhishek- our group chats and friday night video
calls have seen me through what would have been a very lonely and difficult year. Thank you! I
am also very grateful to have had Sarah Brunty as a friend and companion through this journey
v

we both started together in 2016. I would also like to thank Carla and Julia and every person who
has worked or is currently working at MIIR.
I owe all my success through these past five years to everyone mentioned here and more!

vi

TABLE OF CONTENTS
Approval of Thesis .......................................................................................................................... ii
Dedication ...................................................................................................................................... iv
Acknowledgements ......................................................................................................................... v
List of Tables ................................................................................................................................. ix
List of Figures ................................................................................................................................. x
Abstract ......................................................................................................................................... xii
Chapter 1 ......................................................................................................................................... 1
Introduction ......................................................................................................................... 1
Renal Proximal Tubule: Structure and Function .................................................... 3
NKA as an Ion-Pump: Classic role in RPT Na+ transport ...................................... 7
Non-Enzymatic Functions of NKA in RPT .......................................................... 15
Pathological importance of RPT NKA ................................................................. 23
A Natriuretic Role for NKA in RPT ..................................................................... 27
Chapter 2 ....................................................................................................................................... 29
Na/K-ATPase Signaling Tonically Inhibits Sodium Absorption in the Renal Proximal
Tubule ............................................................................................................................... 29
Abstract ................................................................................................................. 30
Introduction ........................................................................................................... 30
Results ................................................................................................................... 34
Discussion ............................................................................................................. 55
Acknowledgements ............................................................................................... 61
Materials and Methods .......................................................................................... 62

vii

Chapter 3 ....................................................................................................................................... 72
Renal Proximal Tubule-Specific Alteration of the NKA/Src Receptor Complex in the
Mouse: Evidence for Sexual Dimorphism ........................................................................ 72
Introduction ........................................................................................................... 72
Materials and Methods .......................................................................................... 74
Results ................................................................................................................... 78
Discussion ............................................................................................................. 93
Chapter 4 ....................................................................................................................................... 97
Discussion and Conclusions ............................................................................................. 97
Functionally dominant natriuretic signaling through NKA 1 in RPT Na+
transport ................................................................................................................ 97
NKA 1 non-enzymatic regulation of NHE3 and NBCe1A. ............................... 98
Sexual Dimorphism in NKA/Src-mediated inhibition of RPT Na+ absorption. . 101
Clinical implications. .......................................................................................... 104
Future studies ...................................................................................................... 106
References ................................................................................................................................... 107
Appendix A ................................................................................................................................. 136
Letter from Office of Research Integrity ........................................................................ 136
Appendix B ................................................................................................................................. 137
Abbreviations .................................................................................................................. 137
APPENDIX C ............................................................................................................................. 144
License for PNAS articles ............................................................................................... 144

viii

LIST OF TABLES
Table 1: Systemic and local factors regulating RPT NKA in Na+ transport. ................................ 14
Table 2: Basal metabolic characteristics and Body Composition Analysis by EchoMRI. ........... 38
Table 3: Basal metabolic characteristics of SGLT2-Cre mice...................................................... 40
Table 4: Urine chemistry panel of RPTα1-/- and control RPTα1+/+ mice. .................................... 44
Table 5: Serum chemistry panel of RPTα1-/- and control. ............................................................ 44
Table 6: Basal metabolic characteristics of RPTα1-/-NHE3-/-mice. .............................................. 48
Table 7: Amino acid sequences of the Src binding sites of the WT rat α1, loss-of-function
signaling mutant α1 NKA, WT rat α2, and gain-of-function signaling mutant α2 NKA expressed
by the AAC-19, Y260A, LX-α2, and LY-a2 cell lines. ................................................................ 54
Table 8: Basal metabolic characteristics of male RPTα1WT mice. ................................................ 81
Table 9: Basal metabolic characteristics of female RPTα1WT mice.............................................. 82
Table 10: Basal metabolic characteristics of male RPTα1Y260A mice. .......................................... 82
Table 11: Basal metabolic characteristics of female RPTα1Y260A mice. ....................................... 82
Table 12: Urine chemistry panel of male RPTα1WT and their controls (RPTα1control). ................ 85
Table 13: Urine chemistry panel of female RPTα1WT and their controls (RPTα1control). ............. 86
Table 14: Urine chemistry panel of male RPTα1Y260A mice and their controls (RPTα1control). .... 86
Table 15: Urine chemistry panel of female RPTα1Y260A mice and their controls (RPTα1control). . 87
Table 16: Serum chemistry panel of male RPTα1WT and their controls (RPTα1control). ............... 87
Table 17: Serum chemistry panel of female RPTα1WT and their controls (RPTα1control). ............ 88
Table 18: Serum chemistry panel of male RPTα1Y260A mice and their controls (RPTα1control).... 88
Table 19: Serum chemistry panel of female RPTα1Y260A mice and their controls (RPTα1control). 89

ix

LIST OF FIGURES
Figure 1: Transport of Solutes and water in RPT. .......................................................................... 6
Figure 2: Albers-Post mechanism of active transport by NKA. ................................................... 10
Figure 3: NKA enzymatic ion-pumping function in RPT Na+ transport. ..................................... 12
Figure 4: Non-enzymatic regulatory function of NKA in RPT Na+ transport. ............................. 23
Figure 5: Genetic ablation of 90% of NKA 1 in renal epithelial cells leads to increased
transepithelial Na+ transport, decreased phosphorylation(ser552)-mediated inactivation of NHE3,
and increased total NBCe1A. ........................................................................................................ 35
Figure 6: Proximal tubule-specific Atp1a1 ablation. .................................................................... 37
Figure 7: NKA α1 expression in the RPT α1 hypomorphic mouse. ............................................. 38
Figure 8: Morphometric and Histological Analysis of Kidney cross-sections by Periodic Acid
Schiff and Masson’s Trichrome staining in RPTα1-/-. .................................................................. 39
Figure 9: Renal sodium handling in RPTα1-/-. .............................................................................. 42
Figure 10: Urine and Na+ output, Water excretion through alternate routes and Glucose and
Insulin tolerance tests in RPTα1-/-................................................................................................. 43
Figure 11: RPT sodium transporters and sodium reabsorption in RPTα1-/-. ............................... 47
Figure 12: Proximal-tubule specific Atp1a1 and NHE3 ablation. ................................................ 49
Figure 13: Loss of NKA α1 leads to dismantlement of NKA/Src receptor complex in RPT cells.
....................................................................................................................................................... 51
Figure 14: Loss of Src-binding in NKA 1 reduces NHE3 inhibitory phosphorylation at ser552
and increases NBCe1A in RPT cells. ........................................................................................... 55
Figure 15: Scheme depicting Classic vs Dual function of NKA in RPT Na+ reabsorption and
corresponding predicted phenotype of the hypomorphic RPT1-/- mouse. .................................. 60

x

Figure 16: Strategy for RPT-specific Wild-type and Y260A signaling mutant Atp1a1 rescue in
mouse. ........................................................................................................................................... 80
Figure 17: Generation of RPT-specific Wild-type Atp1a1 rescue mouse model. ........................ 81
Figure 18: Generation of RPT-specific Y260A signaling mutant NKA α1 rescue mouse model. 83
Figure 19: Rescue with Src-binding Y260A NKA α1 mutant decreases natriuresis and diuresis in
sex-dependent manner. ................................................................................................................. 84
Figure 20: Female RPTα1Y260A mice exhibit increased RPT Na+ absorption. .............................. 90
Figure 21: Membrane abundance of NHE3 in Male and Female RPTα1 Y260A. ............................ 91
Figure 22: C57Bl/6 female mice exhibit increased phosphorylation of Src-binding Y260 residue
of NKA α1 under basal conditions. .............................................................................................. 93

xi

ABSTRACT
The renal proximal tubule (RPT) is the center stage for renal handling of Na+, a potent
determinant of systemic Na+ and volume homeostasis in health and disease. In the RPT, through
its classic ion-pumping function, Na+/K+-ATPase (NKA) generates the Na+ gradient that drives
apical Na+ absorption, mostly through Na+/H+ exchanger (NHE3). In contrast, pharmacological
evidence suggests that the activation of the NKA non-enzymatic signaling function, through Src
and other signaling partners, triggers a cellular redistribution of NKA and NHE3 that decreases
transcellular Na+ flux in cultured RPT cells. However, the physiological relevance of the nonenzymatic function of NKA compared to its enzymatic function in the regulation of RPT Na+
transport has not been directly studied. Thus, to address this, we developed a genetic approach
in RPT cells and mice. Loss of NKA α1 in RPT cells in vitro and in vivo resulted in a prominent
increase in transepithelial Na+ transport coupled to an increased membrane abundance of apical
NHE3 and basolateral Na/HCO3- cotransporter-1A (NBCe1A). Consistently, the hyperabsorptive phenotype observed in RPT-specific hypomorphic NKA α1 mice was rescued upon
crossing with RPT-specific hypomorphic NHE3 mice, confirming the importance of NKA/NHE3
coupling. Consistent with previous pharmacological studies reported a role for Src in the
natriuretic regulation by NKA receptor, rescue of RPT cells with wild-type but not Src-binding
null NKA α1 restored NHE3 and NBCe1A to basal levels, indicative of a role for NKA/Src
receptor function in the tonic inhibition of Na+ transporters in vitro. In vivo, while female mice
expressing Src-binding mutant NKA α1 in RPT exhibit increased NHE3 and RPT Na+ transport,
male mice exhibit no change. These observations are compatible with a sexual dimorphism in the
NKA/Src mechanism of regulation of NHE3 and Na+ transport in the RPT. Hence, NKA nonenzymatic signaling is a potent natriuretic mechanism of tonic inhibition of RPT Na+ transport

xii

by regulating key apical and basolateral Na+ transporters. Remarkably, the natriuretic NKA
signaling is also functionally dominant over its classically recognized anti-natriuretic ionpumping role. NKA signaling therefore provides a long sought-after mechanism for the
natriuretic action of endogenous NKA ligands such as cardiotonic steroids.
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CHAPTER 1
INTRODUCTION
Hypertension, a condition of chronically elevated blood pressure of 140/90mmHg or
more in humans, is one of the most common chronic diseases affecting over a billion people
worldwide (Iqbal & Jamal, 2019; Lawes, Vander Hoorn, & Rodgers, 2008; Lloyd-Jones et al.,
2010). Despite a wide prevalence of hypertension, a substantial portion of affected individuals
does not achieve the target level of blood pressure control recommended by current guidelines
(Tocci, Presta, Ferri, Redon, & Volpe, 2020). A major factor contributing to these poor outcomes
is the gap in our understanding of the pathogenesis of hypertension. As many as 90% of the
hypertensive cases are diagnosed as essential or idiopathic hypertension, i.e., hypertension
caused from internal dysfunction of unknown cause (Iqbal & Jamal, 2019; Lawes et al., 2008;
Lloyd-Jones et al., 2010). Interestingly, about half of the hypertensive cases are also classified as
salt-sensitive hypertension making Na+ and its systemic handling a major factor influencing the
development of this chronic disease (Iqbal & Jamal, 2019; Lloyd-Jones et al., 2010; Sacks et al.,
2001).
In 1909, Ernest Henry Sterling, in his landmark lecture series of ‘The Fluids of the Body’
stated that: “The function of the kidney is to keep the composition of the circulating fluid
constant, and we can therefore alter the urine in any direction according to the nature of the
changes we bring about in the composition of the body” (Starling, 1909). Decades later, Guyton
and colleagues confirmed Sterling’s foresighted postulates when they noted changes in urinary
Na+ and water excretion with changes in arterial pressure in intact animals and proposed a central
role for the kidneys in the regulation of blood pressure, and as a corollary a key target for the
pathogenesis of hypertension (Guyton, 1991; Guyton et al., 1972). The latter was confirmed by
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kidney cross-transplantation studies in strains of hypertensive rats, in which an elevated blood
pressure in the normotensive rat receiving the hypertensive donor kidney was observed (Bianchi,
Fox, Di Francesco, Bardi, & Radice, 1973; Bianchi, Fox, Di Francesco, Giovanetti, & Pagetti,
1974; Churchill, Churchill, & Bidani, 1992).
Under normal physiological conditions, the kidney reabsorbs as much as 99% of the Na+ in the
filtered luminal fluid. Every thirty minutes, the kidney filters the entire plasma fluid and almost
two-thirds of the Na+ is bulk reabsorbed in the renal proximal tubule (RPT) which forms the
earliest tubular segment of renal nephron. Studies in various cellular and animal models have
shown that RPT has a major role in renal and systemic Na+ handling and associated blood
pressure homeostasis (Burnier, Bochud, & Maillard, 2006; Chiolero, Maillard, Nussberger,
Brunner, & Burnier, 2000; Doris, 2000; McDonough, 2010b; Zhuo & Li, 2013). This
homeostatic function requires the presence of many specific carriers to transport a large variety
of substrates and their fine control by endogenous factors and hormones. The Na/K-ATPase
(NKA) protein complex is expressed abundantly on the basolateral membrane of the polarized
epithelial cells of the RPT. NKA has been at the forefront of studies to understand the
mechanisms and regulations of RPT-mediated Na+ transport, salt-sensing, and hypertension
(Aperia, Bertorello, & Seri, 1987; Beach, Schwab, Brazy, & Dennis, 1987; De Wardener &
Clarkson, 1985; De Wardener, Millett, Holland, MacGregor, & Alaghband-Zadeh, 1987; Doris,
2000; Katz, 1982; Maude, 1969; Nishi, Bertorello, & Aperia, 1992; Obando, Marín, Proverbio,
& Proverbio, 1987; Pedemonte, Efendiev, & Bertorello, 2005b; Periyasamy et al., 2005; Rector
Jr, 1983; Y. Zhang et al., 1998). In addition to its traditional ion-pumping function, the past few
decades have seen an increase in awareness of the more recently identified non-enzymatic
functions of NKA in studies spearheaded by independent groups worldwide (Aydemir-Koksoy,
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Abramowitz, & Allen, 2001; Barwe et al., 2005; Haas, Askari, & Xie, 2000; Huang, Li, & Xie,
1997; Lee, Jung, Kim, & Guidotti, 2001; Miyakawa-Naito et al., 2003; Yan et al., 2013; L.
Zhang, Zhang, Guo, & Wang, 2008). Specifically in the RPT, in vitro and pharmacological
studies demonstrate NKA receptor-mediated regulatory function in Na+ transport (ArnaudBatista et al., 2012; H. Cai et al., 2008; Godinho et al., 2017; Liu et al., 2011). Even though
several studies demonstrate NKA receptor-mediated inhibition of Na+ transport in RPT cells, the
physiological relevance of the non-enzymatic receptor function of NKA compared to its
enzymatic function in the regulation of RPT Na+ transport has not been extensively studied.
Thus, considering the importance of RPT Na+ absorption in human health and disease, we
explored the importance of the NKA non-enzymatic signaling in the regulation of RPT Na+
transport.
Renal Proximal Tubule: Structure and Function
Physiology and Pathophysiology
RPT is the earliest nephron tubular segment comprising of the proximal convoluted
tubule followed by a proximal straight tubule (Wilhelm Kriz & Bankir, 1988; Wand Kriz &
Kaissling, 2013; Zhuo & Li, 2013). It is responsible for most of the renal reabsorption with twothird of solutes, comprising of ions and organic nutrients, absorbed iso-osmotically (water and
solutes in equal proportion) by the RPT. The proximal convoluted tubule forms the early S1 and
S2 regions of the whole proximal tubule (Wilhelm Kriz & Bankir, 1988) and the region we are
primarily referring to as RPT in this dissertation. It is in this S1 and S2 segments that most of
the Na+ in the proximal tubule is absorbed (Wand Kriz & Kaissling, 2013). Structurally, RPT has
an optimal design for reabsorbing the bulk of the glomerular filtrate. It is characterized by leaky
polarized epithelial cells with a thick apical brush border membrane which has microvilli
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projections that increases the surface area for such bulk reabsorption (Wand Kriz & Kaissling,
2013; Zhuo & Li, 2013). The basolateral membrane of RPT comprises of extensive lateral
invaginations and a closely associated large network of mitochondria that supports the highenergy demands of the basolateral expressed NKA (Wand Kriz & Kaissling, 2013). The active
extrusion of Na+ by NKA sets the electrochemical gradient for transporters expressed on the
apical brush border membrane to couple Na+ transport to that of specific solutes such as: glucose,
sulfate, amino acids, phosphate, bicarbonate, and organic acids for their transcellular absorption.
The leaky junctions between RPT cells gated by tight junction (TJ) proteins are a route of
reabsorption for ionic solutes, like Na, K+, Cl-, Ca2+, Mg2+, along with water (Anderson & Van
Itallie, 1995; Muto et al., 2010). As depicted in Figure 1, both transcellular transporters and
paracellular junction proteins contribute to the bulk transport of solutes and water in RPT.
RPT functions are essential to renal Na+ handling and systemic Na+ and volume
homeostasis. One such role is in the maintenance of glomerulotubular balance (GTB), a
phenomenon by which changes in glomerular filtration rate (GFR) is accompanied by
proportional changes in RPT absorption to minimize Na+ wasting or prevent cessation of tubular
excretion (Landwehr, Schnermann, Klose, & Giebisch, 1968). Dependent on GTB, any major
fluctuations in GFR or RPT absorption influences Na+ delivery to macula densa cells in distal
tubule which then activates the tubuloglomerular feedback (TGF) mechanism to counteractively
modulate GFR(Palmer & Schnermann, 2015). Although the molecular mechanisms of GTB are
poorly understood, flow-dependent and mechanosensory changes are implicated in the
adaptation of RPT Na+ transport to GFR (Bartoli, Conger, & Earley, 1973; Du et al., 2004; Duan,
Weinstein, Weinbaum, & Wang, 2010b; Palmer & Schnermann, 2015). Another function of RPT
in Na+ homeostasis involves its role in the mechanism of pressure natriuresis to restore systemic
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homeostasis. Pressure natriuresis is the phenomenon of reduced Na+ absorption and increased
excretion in response to increased renal perfusion pressure, independent of GFR and TGB
(Arendshorst, 1979; Arendshorst & Beierwaltes, 1979a). Depressed RPT Na+ transport is the
major contributing factor to this homeostatic response (Arendshorst & Beierwaltes, 1979b).
Renal interstitial hydrostatic pressure (RIHP), nitric oxide (NO), and salt-sensing, all play a role
in RPT’s role in the pressure natriuresis response (Carlström, Wilcox, & Arendshorst, 2015;
Hallow, Helmlinger, & Gebremichael, 2016), however the mechanisms are not completely
understood. These functions are in addition to the modulation of RPT Na+ absorption by
numerous hormones, endogenous factors, and neuronal stimulation to maintain homeostasis
(Aperia et al., 1987; Beach et al., 1987; Chiolero et al., 2000; Cogan, 1990; Cogan & Rector Jr,
1982; McKinney & Myers, 1980; T. Wang, Egbert Jr, Aronson, & Giebisch, 1998).
Despite the importance of RPT functions to the renal regulation of blood pressure, the distal
nephron was traditionally attributed with the regulation of Na+ and volume homeostasis through
‘fine-tuning’ and considered as the key pathological target for hypertension. Investigations in
gene knockout animals along with clinical case studies have found the defects in Na+ transport in
the distal nephron to be associated with the rare monogenic and congenital forms of hypertension
(Boscardin et al., 2018; Burnier et al., 2006; Lifton, Gharavi, & Geller, 2001; Rossier,
Pradervand, Schild, & Hummler, 2002; Schultheis et al., 1998). However, several animal models
and clinical studies, pertaining to the more prevalent polygenic hypertension, report an impaired
and hyper-reabsorptive RPT associated with salt-sensitive hypertension (Bianchi et al., 1994;
Burnier et al., 2006; Doris; Roos, Kirchner, Abernethy, & Langford, 1984; Thomas, Harris, &
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Morgan, 1988). Thus, defining the molecular machineries involved in Na+ sensing and
absorptive functions of RPT is critical to our understanding of essential hypertension.

Figure 1: Transport of Solutes and water in RPT.
Scheme depicting several of the apical and basolateral transporters involved in transcellular
transport along with the paracellular transport gated by tight junction (TJ) proteins to reabsorb
solute and fluid in RPT. SGLT2: Na+/Glucose cotransporter-2; NHE3: Na+/H+ exchanger-3;
NaPi2a: Na+/PO43- cotransporter-2a; NaSi-1: Na+/SO42- cotransporter-1; Aqp-1: Aquaporin-1;
NKA: Na+/K+-ATPase; NBCe1A: Na+/HCO3- cotransporter-1A. Created by Biorender.
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Sexual Dimorphism
The structure and function of the kidneys show sexual dimorphism in mammals (R. Hu,
McDonough, & Layton, 2020; Q. Li, McDonough, Layton, & Layton, 2018; Veiras et al., 2017).
In rodents, there are sex-dependent differences in the expression of renal transporters including a
decrease in RPT transporters NHE3, Na+/PO42- (NaPi2a), and paracellular tight junction protein
claudin-2, and an increase in distal tubule transporters Na+/K+/Cl- cotransporter (NKCC2) and
Na+/Cl- cotransporter (NCC), in females compared to males (Veiras et al., 2017). This
functionally translates to a decreased dependence on RPT-mediated bulk Na+ absorption and
higher Na+ absorption in the distal tubule in females compared to males (Q. Li et al., 2018;
Veiras et al., 2017). The sex-dependent differences could also be indicative of a tighter
regulation of RPT absorption in the female rodents. The distinction in the distribution of Na+
absorption across the nephron may be important to the sex-dependent differences in the
flexibility and adaptability required to compensate for tubular defects.
Since RPT plays a crucial role in the homeostatic response to an elevated blood pressure,
the sex-dependent differences may underlie a sexual dimorphism in systemic mechanisms of Na+
and volume homeostasis. Indeed, women exhibit lower basal blood pressure and show decreased
risk and severity of hypertension than men (Mozaffarian et al., 2016; Song, Ma, Wang, Chen, &
Zhong, 2020). Therefore, elucidating the mechanisms underlying the sexual dimorphism in RPT
Na+ transport is vital to understanding the role of gender in pathogenesis of hypertension.
NKA as an Ion-Pump: Classic role in RPT Na+ transport
Molecular composition and enzymatic functions of the renal NKA
The discovery of NKA in 1957 (Skou, 1957) by 1997 Nobel laureate Jens Skou was a
defining moment in cellular physiology, which eventually paved the way for the identification
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and characterization of the critical role of NKA enzymatic activity in RPT Na+ reabsorption
(Glynn, 1985; Gottschalk, 1962; Katz & Epstein, 1967; Maude, 1969; Ullrich et al., 1963;
Whittembury, 1965; Windhager & Giebisch, 1961). A cornerstone of kidney transport
machinery, NKA is a ubiquitous plasma membrane P-type ATPase protein that is highly
conserved in eukaryotic cells. It is comprised of two subunits: catalytic α subunit (4 isoforms),
and a membrane-trafficking and stabilizing β subunit (3 isoforms) (Blanco & Mercer, 1998). The
kidney and the RPT mainly express a combination of α1 and β1 in the basolateral membrane,
closely surrounded by mitochondria in the RPT cells. The catalytic α subunit, with a molecular
mass of approximately 110 kDa, comprises of 10 transmembrane domains M1 to M10 with
binding sites for Na+ and ATP in the cytoplasmic domain and the binding sites for K+ and
cardiotonic steroids at the extracellular domain (Blanco & Mercer, 1998; Lingrel & Kuntzweiler,
1994; Mercer, 1993; Pressley, 1996). The glycosylated β glycoprotein subunit, with a molecular
mass of 31.5 kDa, is functionally crucial for the efficient membrane trafficking of the α subunit,
the expression of the enzyme on the plasma membrane, induction of tight junction assembly and
polarity in epithelial cells, and in cell-cell adhesion function (Bab-Dinitz et al., 2009; Blanco &
Mercer, 1998; D. C. Chow & Forte, 1995; McDonough, Geering, & Farley, 1990; Rajasekaran et
al., 2001). The αβ complex forms the functional dimeric unit of sodium pump based on current
evidence (Glynn, 1985; Glynn, 1993; Jørgensen, Håkansson, & Karlish, 2003; Skou & Esmann,
1992). FXYD proteins, which belong to family of single span membrane proteins characterized
by the conserved FYXYD motif, bind to NKA to modulate its properties in a tissue-specific way
but is not necessary to its pumping function itself. FXYD2, also referred to as γ, is expressed in
the kidney with RPT cells expressing splice variant FYXYD2a. FXYD2 regulates the NKA
enzymatic activity by decreasing Na+ affinity and Vmax and the animal knockouts exhibit
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increased renal cortical NKA activity but show no change in basal renal function (Arystarkhova
& Sweadner, 2005; Jones et al., 2005).
NKA undergoes conformation changes on hydrolysis of ATP to pump 3Na+ out and 2K+
into the cell against their respect electrochemical gradients. Per the Albers-Post model (Figure
2)(Albers, 1967; Post, Hegyvary, & Kume, 1972), NKA and other P-type ATPases (Sachs &
Munson, 1991) cycle through two main conformational states that can be either
unphosphorylated (E1 and E2) or phosphorylated (E1P and E2P) and are characterized by their
respective affinities for Na+, K+, and ATP, and by the accessibility of the cationic sites at the
intracellular or extracellular sides of the membrane (Albers, 1967; Post et al., 1972). Na+, ATP
and Mg2+ bind to E1 on the intracellular side of the pump, promoting the phosphorylation of E1.
After release of ADP, the exergonic trans-conformation of E1P to E2P occurs, which promotes
the extracellular delivery and release of the occluded Na+ followed by the binding of
extracellular K+. Binding of K+ induces the dephosphorylation of E2P. Spontaneous reversion to
E1 releases the occluded K+ inside the cell, thereby completing one entire reaction cycle (Albers,
1967; Post et al., 1972). Because of its 3Na+/2K+ stoichiometry, the pump is electrogenic, and
generates a negative electric potential difference across cell membrane. By generating the
electrochemical gradient of Na+ and K+, NKA not only maintains the membrane potential but
also performs the vital function of cell volume regulation. Indeed, NKA’s expression and activity
are altered to adapt to hypertonic or hypotonic challenges to maintain the cell volume (Yordy &
Bowen, 1993).
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Figure 2: Albers-Post mechanism of active transport by NKA.
Schematic of active transport of 3Na+ and 2K+ by NKA through changes in its conformation as
described by the Albers-Post mechanism. Encircled P indicates phosphorylation status of NKA
conformation. Created by Biorender.
Transcellular Na+ Transport in the RPT
As early as 1961, Windhager and Giebisch identified the active nature of transcellular
Na+ transport and postulated that it was the primary mechanism of Na+ transport in the RPT
based on early short circuit experiments on rat kidneys (Windhager & Giebisch, 1961). The
kidney is a rich source of NKA, and the abundantly expressed basolateral NKA drives the active
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transcellular Na+ transport across renal epithelium including RPT cells (Gottschalk, 1962; Hook,
1969; Jørgensen, 1980; Maude, 1969; Schatzmann, Windhager, & Solomon, 1958). Most of our
current knowledge on the role and contribution of NKA ion-pump in RPT Na+ transport is based
on early pharmacological studies using ouabain (Hook, 1969; Maude, 1969; Schatzmann et al.,
1958). Like other cardiotonic steroid (CTS), ouabain is a natural and potent inhibitor of NKA.
Ouabain binds extracellularly to NKA under its E2P conformation, decreasing its affinity for K+
and competitively inhibits its enzymatic activity (Yatime et al., 2011). Various CTS have been
isolated and identified endogenously in plants and animals, including in human beings (Bagrov,
Fedorova, Austin-Lane, Dmitrieva, & Anderson, 1995; Hamlyn et al., 1991; Laredo, Hamilton,
& Hamlyn, 1995).
In RPT, around 25-50 million NKA units are expressed in each cell (El Mernissi &
Doucet, 1984; Jørgensen, 1980). However, the assessment of NKA ion-transport activity in situ
with the ouabain-sensitive rubidium uptake indicates that the enzymatic pump is working at 20–
30% of its maximum rate in intact cells (Cheval & Doucet, 1990; El Mernissi & Doucet, 1984;
Féraille & Doucet, 2001). This proportion is consistent with measurements of intracellular Na+
concentration and Na+ affinity (Cheval & Doucet, 1990; El Mernissi & Doucet, 1984; Féraille &
Doucet, 2001). The redundancy in expression of NKA has been proposed as an indicator of the
non-enzymatic functions of NKA.
Na+ transport across RPT epithelia is dynamically controlled by changing apical
Na+ entry coupled with basolateral Na+ exit to increase or decrease absorption. Most of the
luminal Na+ along the early RPT is apically transported by the Na+/ H+ exchanger-3 (NHE3) in
exchange for proton (Wu, Biemesderfer, Giebisch, & Aronson, 1996). As depicted in Figure 3,
the electrochemical gradient generated by NKA drives the Na+ absorption predominantly by
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apical NHE3. Other Na+-dependent transporters and paracellular pathway also contribute to the
total transepithelial flux (Figure 1). The uptake of Na+ in exchange for H+ secretion by NHE3
also results in luminal bicarbonate (HCO3-) uptake by the RPT cells, which is transported along
with Na+ by basolateral Na+/ HCO3- cotransporter-1A (NBCe1A). Other important apical Na+
transporters also utilize the Na+ gradient set by NKA to transport glucose (SGLT-2), phosphate
(NaPi-2a), sulfate (NaSi-1), and amino acids and several organic acids, along with Na+.

Figure 3: NKA enzymatic ion-pumping function in RPT Na+ transport.
Basolateral pumping of 3Na+ out and 2K+ into the cell generates an electrochemical gradient that
drives apical sodium transporters like NHE3 (predominant apical Na+ transporter) to reabsorb
Na+ from the lumen down its concentration gradient. Lightning sign depicts the use of energy in
the active transport of Na+ by NKA.
Regulation of NKA Enzymatic Function
The importance of the regulation of Na+ and fluid reabsorption by the RPT is wellillustrated by the many hormones, neurotransmitter, and endogenous factors that target RPT Na+
12

transport. Elegant studies over the past few decades have identified dopamine, angiotensin-II,
endogenous CTS, parathyroid hormone (PTH), epinephrine and norepinephrine, insulin,
glucocorticoids, aldosterone, endothelin, NO, and shear stress to modulate RPT Na+ transport
(Table 1). Much of these natriuretic and anti-natriuretic factors regulate the RPT Na+ absorption
by targeting membrane abundance and activity of NKA and apical NHE3 by concerted but
independent signaling pathways.
The mechanism of regulation of RPT Na+ transport by the hormones dopamine and
angiotensin-II has been the premise of a large number of studies aiming to understand the
nuances of blood pressure regulation. Both hormones are synthesized locally by RPT cells
(Kobori, Harrison-Bernard, & Navar, 2001; Soares‐da‐Silva, Fernandes, & Pinto‐do‐OA, 1994).
Dopamine inhibits NKA activity through D1 receptor mediated activation of phosphoinositide 3kinase IA (PI3K-IA) via protein kinase C-δ (PKCδ), as well as through the activation of cyclic
adenosine monophosphate (cAMP)- protein kinase A (PKA) pathway. Conversely, angiotensinII at lower 10-12-10-10M concentration stimulates NKA activity through AT1 receptor-mediated
activation of PKCβ that leads to phosphorylation of NKA at Ser-11 and 18 that increases NKA
affinity for Na+. Newer reports indicate that phosphorylation at Ser-938 of NKA along with Ser18 increases membrane recruitment of NKA. Therefore, Na+ excretion is bi-directionally
regulated by dopamine and angiotensin-II.
Notably, Efendiev et al. (2003) demonstrated that opossum kidney (OK) cells treated
simultaneously with saturating concentrations of dopamine and angiotensin-II depend on
intracellular [Na+] to determine the pathway controlling NKA activity. The authors suggest that
an intracellular Na+ sensor/s of yet unknown molecular identity may act as a master regulator of
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the hormone-modulated Na+ transport in the RPT (Efendiev, Budu, Cinelli, Bertorello, &
Pedemonte, 2003).
Numerous preclinical and clinical studies, dating back as early as 50 years ago, have
indicated a role for endogenous CTS in regulation of natriuresis. However, early inconsistencies
in assay-based detection of endogenous CTS resulted in a period of disinterest in endogenous
CTS and the questioning of its importance to human physiology. Several recent advances and
discoveries including, advances in detection methodologies, the identification of NKA nonenzymatic functions, and studies in mice expressing NKA α1 transgene with increased ouabain
sensitivity, have established endogenous CTS as an important physiological regulator.
Subsequently, there is a renewed research interest to elucidate the mechanism of action
underlying its natriuretic function in health and disease (Bagrov, Shapiro, & Fedorova, 2009;
Haas, Wang, Tian, & Xie, 2002; Huang et al., 1997; Loreaux, Kaul, Lorenz, & Lingrel, 2008).
Factor

Effect on
RPT NKA

Effect on RPT
Na+ transport

Reference

PTH

Inhibition

Inhibition

(Y. Zhang et al., 1999)

Norepinephrine

Stimulation

Stimulation

(Beach et al., 1987)

Aldosterone

Stimulation

Stimulation

(Salyer et al., 2013)

Nitric Oxide

Inhibition

Inhibition

(Mingyu Liang & Knox, 1999)

Insulin

Stimulation

Stimulation

(Féraille et al., 1999)

Endothelin

Inhibition

Inhibition

(Garvin & Sanders, 1991)

Fluid Shear
Stress

Stimulation

Stimulation

(Duan, Weinstein, Weinbaum, &
Wang, 2010a)

Inhibition

Inhibition

(Periyasamy et al., 2005)

Endogenous
marinobufagenin

Table 1: Systemic and local factors regulating RPT NKA in Na+ transport.
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Non-Enzymatic Functions of NKA in RPT
Endogenous Cardiotonic Steroids: Effect on RPT and their role as the ‘Third
Factor’
British physician William Withering provided the first written scientific and medicinal
account of digitoxin containing foxglove in 1795 (Withering, 2014). CTS specifically bind to
extracellular sites on TM1-TM2, TM5-TM6, and TM7-TM8 loops of the alpha subunit of the
NKA (Burns, Nicholas, & Price, 1996; Croyle, Woo, & Lingrel, 1997). Species and isoformspecific differences in sensitivity to CTS binding can be attributed to differences in amino acid
sequences of these CTS binding sites. Indeed, R111Q and D122N mutations in the CTS binding
sequence confers ouabain sensitivity to the resistant rat NKA α1(Jewell & Lingrel, 1991). The
species-specific difference in CTS sensitivity was utilized to establish physiological importance
of endogenous CTS (Loreaux et al., 2008; Wansapura, Lasko, Lingrel, & Lorenz, 2010).
Even prior to the discovery of NKA, Szent-Gyory in 1953 hypothesized that digitalis
drugs substitute for compounds circulating endogenously in the human body- at that time
referring to its function in cardiac function (Mullins, 1954). The high affinity and specificity of
NKA for the plant-derived inhibitor ouabain further drove scientists to search for the existence of
endogenous analogs.
In 1961, De Wardener elegantly demonstrated existence of a critical regulatory “Third
factor” in determining renal Na+ handling, in addition to aldosterone and GFR, when natriuresis
by saline infusion was shown to be maintained even in presence of constant renal perfusion
pressure and GFR (De Wardener, 1961). This striking finding was followed by a plethora of
work in confirming and identifying the third factor (Buckalew, Martinez, & Green, 1970; Cort &
Lichardus, 1963; De Wardener et al., 1971; Kramer & Gonick, 1974; Schrier, McDonald,
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Marshall, & Lauler, 1968; Schrier, Verroust, et al., 1968). In the early 90s, Hamlyn et al. isolated
a compound from the human plasma that was indistinguishable from the plant-derived ouabain
and thereby named it endogenous ouabain (EO) (Hamlyn et al., 1991). The adrenal cortex and
hypothalamus are both a source of the EO (Goto et al., 1996) (Laredo et al., 1995) (Hamlyn et
al., 1991; Komiyama et al., 2001; Murrell et al., 2005). Adrenocorticotrophic hormone (ACTH),
angiotensin-II, vasopressin, and phenylephrine, all stimulate EO synthesis, and ACTH-induced
hypertension is associated with elevation in plasma levels of EO (Laredo, Shah, Lu, Hamilton, &
Hamlyn, 1997; Shah, Laredo, Hamilton, & Hamlyn, 1999). Other CTS that have been isolated
and identified endogenously in mammals include marinofugenin (MBG), and telecinobufagenin
(TCG) (Komiyama et al., 2005).
EO does not induce natriuresis under basal conditions but arguably has a role in the
adaptation to both Na+ depletion and loading. While in one clinical study of 180 patients with
untreated hypertension, plasma EO remained unchanged during two weeks of salt-loading but
increased during salt-depletion, another study with 13 healthy men reported a tremendous 13fold increase in EO after salt-loading and a 4-fold increase with salt-depletion (Manunta,
Hamilton, & Hamlyn, 2006; Manunta et al., 2001). In mice, conferring ouabain sensitivity to
NKA α1 augmented the natriuretic response to an acute salt load (Loreaux et al., 2008).
Neutralization of endogenous NKA inhibitors with an anti-digoxin antibody fragment in the
ouabain-sensitive mice, returned the Na+ excretion rates to the level of the ouabain-resistant
mice, re-enforcing a natriuretic role for EO in response to sodium-loading (Loreaux et al., 2008).
Endogenous MBG is also elevated in rats and humans in response to salt loading, as well as in
hypertension (Fedorova, Doris, & Bagrov, 1998; Gonick, Ding, Vaziri, Bagrov, & Fedorova,
1998; Periyasamy et al., 2005). In salt-loaded Sprague-Dawley rats, treatment with anti-MBG
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antibody decreases urine Na+ excretion along with substantial increase in RPT rubidium uptake
and NKA enzymatic activity, indicating a role of endogenous MBG in the physiological
adaptation of RPT to salt-loading (Periyasamy et al., 2005).
It is worth nothing that the plasma levels of EO, MBG, and TCG in humans are in the
picomolar-nanomolar range in health and disease, a circulating concentration that is considerably
lower than the range required for significant enzyme inhibition and subsequent changes of
intracellular ion homeostasis (Hamlyn et al., 1991; Liu et al., 2002). However, CTS in the range
of endogenous concentration can bind to NKA and activate its non-enzymatic functions. Despite
numerous studies highlighting a physiological role of endogenous CTS in regulation of RPT Na+
transport, investigation of its direct tissue-specific role and mechanism has been fraught with
challenges due to the ubiquitous expression of its receptor NKA and the systemic distribution of
endogenous CTS. There is a need for studies in transgenic mammalian models with RPT-specific
alterations in NKA α1 sensitivity or expression to evaluate the specific physiological function of
endogenous CTS in RPT Na+ transport.
Discovery of NKA Receptor Function
In the late 1990s, a series of studies by Dr. Zijian Xie and collaborators uncovered a nonenzymatic signaling function of NKA, independent of the enzymatic ion-pump function, with a
role in the regulation of cell growth and proliferation of neonatal rat cardiac myocytes (Haas et
al., 2000; Huang et al., 1997). Subsequently, it became apparent that NKA interacts with
membrane proteins and organizes cytosolic cascades of signaling complexes to regulate gene
expression and cell function in a cell type-dependent manner. Binding of CTS at nanomolar
concentration mirroring concentrations of circulation endogenous CTS modulate NKA
interaction with neighboring proteins and activate protein kinase cascades, including but not
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limited to, c-Src, ERK1/2, PI3K, caveolin-1, and PKC (Pierre & Xie, 2006; Z. Xie, 2003).
Specifically, the signaling NKA resides with its partners in caveolae in the plasma
membrane(Man Liang et al., 2007; H. Wang et al., 2004). Caveolae plays an essential role in the
organization of the non-pumping pool of NKA and its assembly with other proteins as a receptor
complex(Man Liang et al., 2007; H. Wang et al., 2004). In fact, NKA α1 binds to caveolin-1
through a conserved caveolin-binding motif which is necessary to its signaling function but not
enzymatic function (X. Wang et al., 2020).
There is evidence that signaling is α–isoform specific (Madan et al., 2016; Tian et al.,
2006; J. X. Xie et al., 2015). NKA/Src interaction is isoform specific to α1 and involves binding
of NKA α1 to Src through two pairs of domain interactions (Tian et al., 2006). The second
cytosolic domain (CD2) acts as a ligand to Src SH2 domain and is necessary for activation and
targeting of Src (Tian et al., 2006). Specifically, the Y260 residue in CD2 of NKA α1 is the Src
phosphorylation and binding site (Banerjee, Duan, & Xie, 2015). This interaction is constitutive
and independent of NKA conformation and ouabain has no effect on the NKA/Src binding at this
specific site (Tian et al., 2006). The binding to CD2 domain may function as a hinge to keep the
activated Src bound to the signaling NKA for specific and robust signal transmission (Tian et al.,
2006). On the other hand, Src kinase domain binds to a sequence labelled Naktide in the
intracellular CD3 domain of NKA α1 in its E1 conformation (Z. Li et al., 2009; Tian et al., 2006;
J. X. Xie et al., 2015). Binding of ouabain to NKA α1 stimulates a change of conformation from
E1 to E2 which results in the freeing of the Src kinase domain from CD3 and subsequently the
disinhibition of Src to activate downstream signaling molecules (Tian et al., 2006).
Active NKA/Src receptor complex also stimulates increase in reactive oxygen species
(ROS) which in turn stimulates receptor activation to form a positive feedback loop (Yan et al.,
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2013). The NKA/Src/ROS dysregulated loop promotes pathogenesis of diseases like obesity,
steatohepatitis, and uremic cardiomyopathy (Sodhi et al., 2015; Sodhi et al., 2017; Sodhi et al.,
2020). Moreover, through a well conserved LKK motif in its N-terminus, NKA binds and forms
a signaling microdomain with inositol 1,4,5-triphosphate receptor (IP3R) which modulates Ca2+
release from intracellular stores (Miyakawa-Naito et al., 2003; S. Zhang et al., 2006). Ouabain
mediated activation of NKA/IP3R signaling stimulates slow Ca2+ oscillations that activates
nuclear factor kappa-B (NFkB) that inhibits apoptosis and promotes cell proliferation in renal
cells derived from young rats (Aperia, 2012; Fontana, Burlaka, Khodus, Brismar, & Aperia,
2013; J. Li, Zelenin, Aperia, & Aizman, 2006). Thus, NKA receptor-mediated signaling
activated by sub-inhibitory dose of ouabain regulates several cellular physiological functions,
including, cell growth (Huang et al., 1997), proliferation (Haas et al., 2000), apoptotic threshold
(J. Li et al., 2006), cell contact (Larre et al., 2010; Larre et al., 2006), and migration (Barwe et
al., 2005).
In renal epithelial cells lacking 90% of NKA α1 after siRNA-mediated knockdown of α1,
the cells retain 40% of cellular maximal enzymatic activity but have a diminished signaling
capacity, consistent with the aforementioned concept of non-ion pumping NKA units detected in
the RPT cells serving signaling receptor functions (Man Liang, Cai, Tian, Qu, & Xie, 2006; Man
Liang et al., 2007). In addition to CTS, exogenous H2O2 (Y. Wang et al., 2014), ROS (Yan et al.,
2013; Yan, Shapiro, Mopidevi, Chaudhry, Maxwell, Haller, Drummond, Kennedy, Tian, &
Malhotra, 2016), intracellular [Na+], and extracellular [K+] (Ye et al., 2011) also serve as ligands
to NKA receptor in RPT cells.
Coupled Regulation of NHE3 and NKA Membrane Trafficking
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A number of in vitro and in vivo studies suggest that NKA α1 receptor function serves a
regulatory role in RPT Na+ transport. In LLC-PK1 cells, low doses of ouabain treatment
stimulate coupled endocytosis of the basolateral NKA and the apical NHE3 and an overall
decrease in transepithelial Na+ flux, with no detectable change in intracellular [Na+] (H. Cai et
al., 2008; Liu et al., 2002). PP2 and wortmannin, inhibitors of Src family kinase and PI3K,
respectively, suppress this action. This indicates a potential role for both signaling molecules in
the NKA receptor-mediated regulation in vitro (H. Cai et al., 2008). The ouabain-mediated
redistribution of NKA and NHE3 is not species-specific within mammals and stimulated
endocytosis of the transporters in RPT cells from pig, humans, and cells expressing rat NKA
(Yan et al., 2012). Another important characteristic of this regulation is the dependence on
carbonylation modification of NKA at Pro224 for CTS to activate NKA receptor-mediated
inhibition of NHE3 and the Na+ flux in vitro (Yan, Shapiro, Mopidevi, Chaudhry, Maxwell,
Haller, Drummond, Kennedy, Tian, Malhotra, et al., 2016).
Additionally, the administration of an antibody to MBG blocked the inhibition of NKA
and suppressed the natriuresis seen with the high-salt diet in vivo (Periyasamy et al., 2005).
Godinho et al. (2017) demonstrated that in vivo perfusion of sub-inhibitory doses of CTS bufalin,
ouabain, telecinobufagin and marinobufagenin in rat kidney inhibits NHE3 activity and Na+
transport (Arnaud-Batista et al., 2012; Godinho et al., 2017), consistent with in vitro findings (H.
Cai et al., 2008). Inhibition of c-Src and MEK1/2-ERK1/2 in these CTS perfused rat kidneys,
suppresses the effect of bufalin on NHE3 activity, highlighting their role in the regulatory
pathway (Arnaud-Batista et al., 2012; Godinho et al., 2017). Therefore, CTS-mediated activation
of NKA signaling inhibits RPT Na+ transport, counteracting its enzymatic function.
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In contrast to the previous identified hormone-mediated regulations, the proposed nonenzymatic regulatory function of NKA orchestrates not only concerted but also interdependent
inhibition of two prominent Na+ transporters to reduce absorption of Na+ by RPT. Remarkably,
NKA non-enzymatic signaling is activated by changes in intracellular [Na+], with increased Na+
concentration driving the E1/E2 conformational transition that leads to NKA/Src activation in
renal cells, making it a prospective protein for salt sensing (Ye et al., 2011). The proposed
NKA/NHE3 coupling mechanism could also have far-reaching fundamental ramifications, as it
establishes a NKA-based mechanism for the regulation of RPT apical Na+ reabsorption by CTS
and non-CTS modulators of NKA that has remained vastly unexplored. With only 20-30% NKA
engaged in enzymatic function in RPT (Cheval & Doucet, 1990; Féraille & Doucet, 2001), one
can even speculate on a more functionally dominant role for the non-enzymatic regulatory
function of the NKA receptor. The direct genetic evidence supporting a role for NKA signaling
in mammalian physiology is still lacking. This is due, in part, to the ubiquitous expression of
NKA α1 and the challenges of studying the non-enzymatic signaling separately from NKA’s
ATPase-mediated ion-pumping function because the latter is required for the survival of animal
(Barcroft, Moseley, Lingrel, & Watson, 2004). One way of addressing this research gap is
through the generation and study of animal models with RPT-specific alteration of NKA
expression or function.
Paracellular Junction and Polarity
In the RPT, paracellular pathway contributes to atleast one-third of the total Na+
reabsorption. Paracellular reabsorption depends on the transepithelial electrochemical force and
tight junction (TJ) permeability. Madin-Darby canine kidney (MDCK) cells are one of the best
characterized renal epithelial cell line, useful for study of tight junctions (Balkovetz, 2006;
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Cereijido, Robbins, Dolan, Rotunno, & Sabatini, 1978; Gonzalez-Mariscal, De Ramirez, &
Cereijido, 1985; Leighton, Estes, Mansukhani, & Brada, 1970; Taub & Saier Jr, 1979). MDCKII cells, one of two strains of MDCK cells, exhibit properties of RPT epithelium, including a
leaky and low transepithelial electrical resistance (TER) and expression of claudin-II (Balkovetz,
2006; Richardson, Scalera, & Simmons, 1981). Claudin-2 in the RPT forms paracellular
channels with other protein that are selective for small cations like Na+ and K+, small anion like
Cl−, as well as water (Enck, Berger, & Alan, 2018; Muto et al., 2010). While high concentrations
of ouabain (1μM) trigger cell detachment, lower concentrations that do not affect the enzymatic
activity increase TER and decrease the flux of neutral 3 kDa dextran (JDEX), thereby modulating
the permeability and sealing of the TJ in MDCK-II cells (Larre et al., 2010). The phenotype is
accompanied by an increase in the protein expression and distribution patterns of claudins 1, 2,
and 4, without affecting occludins (Larre et al., 2010). The changes in TER, JDEX, and claudins
all depend on c-Src activation and partially on ERK1/2 activation (Larre et al., 2010). Therefore,
CTS through NKA/Src receptor modulate cell–cell contacts and paracellular ionic and non-ionic
transport.
Polarity, another critical characteristic of epithelial cells to transport substances
vectorially, is dependent on proper ciliogenesis. Ciliogenesis is an important determinant of
apical polarity that contributes to apical transport of solutes. Renal cilia also serve as sensors that
respond to changes in tubular flow to regulate transporters and cell transport. Ouabain-mediated
activation of NKA signaling accelerates cilogenesis and modulates ciliary localization of
claudin-2 in an ERK1/2-dependent manner in MDCK-II cells (Larre et al., 2011). Recent
findings implicate cilia in mediating fluid shear stress sensitive mechano-transduction to regulate
apical endocytosis in RPT epithelia (Duan et al., 2010a; Raghavan, Rbaibi, Pastor-Soler,
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Carattino, & Weisz, 2014). Further studies can improve our understanding of the role of NKA
signaling in RPT paracellular transport and ciliogenesis. Figure 4 illustrates a schematic of the
regulatory functions indicated to be mediated by NKA non-enzymatic signaling in the RPT.

Figure 4: Non-enzymatic regulatory function of NKA in RPT Na+ transport.
NKA/Src signaling stimulates coupled endocytosis of NKA and NHE3 resulting in decreased
Na+ flux in RPT (1). NKA/Src signaling indicated to modulate expression of tight junction
proteins to decrease the paracellular transport (2). Stimulation of NKA signaling indicated to
promotes ciliogenesis (3).
Pathological importance of RPT NKA
Impairment of dopamine and angiotensin-II regulation of NKA enzymatic function
The natriuretic dopamine and anti-natriuretic angiotensin-II are both established as
hormone regulators of RPT NKA and Na+ transport, and in the regulation of blood pressure
(Gurley, Allen, & Haase, 2008; M. Zhang et al., 2007). Dahl salt-sensitive rats exhibit a
defective dopamine D1 receptor and adenylate cyclase coupling contributing to a lack of
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inhibition of tubular NKA activity in response to salt and impaired natriuretic capacity in these
rats (Nishi, Eklöf, Bertorello, & Aperia, 1993). A defect in dopamine receptor is also implicated
in the development of salt-sensitive hypertension in C57Bl/6 mice (Escano et al., 2009).
However, dopamine receptor agonists are limited to emergency use for severe hypertension and
generally not prescribed for chronic essential hypertension (Murphy, Murray, & Shorten, 2001).
On the other hand, angiotensin-II levels are reportedly elevated in salt-sensitive
hypertension and the chronic infusion of angiotensin-II in addition to high salt augments the
increase in blood pressure in rats (Kobori, Harrison-Bernard, & Navar, 2002; Susic et al., 2011;
Ying et al., 2012). The action of angiotensin-II on RPT Na+ transport is indicated to have a role
in the pathogenesis of salt-sensitive hypertension (Ramkumar & Kohan, 2013; Ying et al., 2012).
Additionally, treatment of spontaneously hypertensive rats with angiotensin-II receptor (AT1R)
blocker prevents the increase in renal NKA activity and in blood pressure (Queiroz-Madeira et
al., 2010). Angiotensin-II receptor blockers are widely used for treatment of hypertension but
recent clinical investigations have shown varying efficacy of drugs, development of resistance
and complications in some patients despite being treated with one or more blockers (Bomback &
Toto, 2009; Calhoun et al., 2008; Jorde et al., 2000).
With the recent identification of NKA natriuretic regulation in vitro, there is a need to
revisit the molecular mechanisms involved in the dopamine-angiotensin-II axis of regulation, its
impact on NKA receptor vs NKA enzyme, and test for possible interactions or cross-talk with
NKA signaling function. Addressing these research gaps may pave the way to more efficient
anti-hypertension therapeutics.
Elevated Endogenous CTS in Volume Expansion
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Conflicting actions have been proposed for EO in the development and pathogenesis of
hypertension. While some studies report that increase in blood pressure correlates directly with
increased plasma EO concentration in humans (Manunta et al., 1999; Masugi, Ogihara,
Hasegawa, & Kumahara, 1986; Pamnani et al., 1989), others found no change in plasma EO with
Na+ loading in hypertensive humans (Bernini, Paci, Sgrò, Moretti, & Salvetti, 1998; Manunta et
al., 2001). Experimentally, there are differences in the study designs, including study population,
and the routes of administration of salt challenge, which may all contribute to the conflicting
findings. In Dahl salt-sensitive rats with salt-induced hypertension, a prominent model used in
research on salt-sensitive hypertension, a transient increase in circulating EO precedes a
sustained increase in circulating marinobufagenin after acute and chronic salt-loading in these
animals (Fedorova, Lakatta, & Bagrov, 2000; Fedorova, Talan, Agalakova, Lakatta, & Bagrov,
2002). The pro-hypertensive effect of EO is often attributed to stimulation of vasoconstriction.
In contrast, MBG has been implicated in promoting natriuresis and decrease RPT Na+
absorption in response to salt-loading, thereby playing an anti-hypertensive role (Periyasamy et
al., 2005). Pharmacological agents targeting or blocking EO may stimulate vasodilation and
improve blood pressure. However, as a trade-off if the increase in endogenous EO represents a
physiological response to modulate a renal system unable to increase Na+ excretion, blocking EO
could decrease vascular resistance but produce adverse renal effects.
Polymorphisms Affecting NKA Trafficking and Regulation
Point mutations of adducin, a cytoskeletal protein critical for actin assembly, cell surface
exposure of integrins, and cell signaling, is associated with genetic hypertension in the Milan
hypertensive rats and in humans (Bianchi et al., 1994; Ferrandi et al., 1999). The ectopic
expression of the hypertension-variant of human α-adducin in normal cells induces a
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hypertensive phenotype in the cells. The mutation is also associated with dysregulated NKA/Src
complex and exhibit an increase in interaction between α-adducin/Src in HK2 renal cells
transfected with mutant α-adducin (Ferrandi et al., 1999). Notably, this effect is suppressed when
the cells and the hypertensive rats with the mutant α-adducin are treated with rostafuroxin, a
digitoxigenin derivative that selectively disrupts the binding to the cSrc-SH2 domain by mutant
α-adducin and the ouabain-activated NKA (Ferrari, Ferrandi, Valentini, & Bianchi, 2006).
In humans, DNA-sequencing detected a 12-nucleotide long thymidine (12T)
insertion(ins)/deletion(del) polymorphism within a poly-T sequence (38T vs 26T) in the NKA α1
gene (ATP1A1) 5’-regulatory region associated with a decreased risk of hypertension in a male
Sardinian population (Herrera et al., 2015). However, the impact of this polymorphism at the
tissue and cellular-level is poorly understood. The study in the Sardinian population suggests
existence of mutations or variants in promotor, enhancer, or intron sequences, that may impact
NKA expression or its interaction with proteins for non-enzymatic signaling.
Impaired Ouabain Mediated NKA/Src Signaling
Following their in vitro studies identifying active NKA receptor-mediated regulation of RPT Na+
transport, Liu and collaborators reported the failure of both high salt and ouabain to exert a
coordinated regulation of NKA and NHE3 membrane trafficking in RPT cells isolated from Dahl
salt-sensitive rats (Liu et al., 2011). Moreover, ouabain/NKA mediated activation of Src and
ERK was impaired in these salt-sensitive rats (Liu et al., 2011). This study highlighted the
ligand-mediated RPT NKA/Src signaling in regulation of RPT Na+ absorption, with its
impairment leading to salt-sensitivity.
In addition to regulating the predominant Na+ transporters in RPT, Xiao et al (2018)
demonstrated that the impairment of NKA/Src signaling is associated with pathogenesis of

26

hyperuricemia-induced renal tubular injury in human RPT epithelial cells (PTECs) and in
experimentally-induced hyperuricemia rat models (Xiao et al., 2018). RPT is responsible for
almost all renal urate transport and increased serum uric acid level is strongly associated with
development of hypertension (Mazzali et al., 2001). Consistently, mice with PNx-mediated
uremic cardiomyopathy, when treated with pNaktide to inhibit the NKA/Src/ROS amplification
loop, improves cardiac function and attenuates the development of uremic cardiomyopathy (Liu
et al., 2016a). Therefore, the NKA receptor function might be the key to addressing several
unresolved research gaps with a lot of clinical relevance, such as the physiological importance of
NKA in RPT Na+ transport and salt-sensing, the role and mechanism of endogenous CTS in RPT
as a natriuretic hormone, and the physiological relevance of RPT NKA functions in systemic
sodium and volume homeostasis in health and disease.
A Natriuretic Role for NKA in RPT
If the history of NKA has taught us anything, it is that there is more to this ubiquitous
multi-faceted protein than meets the eye. After its discovery, for a long time, NKA was solely
appreciated for its role in maintaining the electrochemical gradient for the transepithelial Na+
transport and was perceived as a housekeeping enzyme. Eventually, elegant studies revealed the
dynamic nature of the pump and its regulation by endogenous hormones and factors to increase
or decrease its activity to modulate Na+ absorption. Recent discoveries have revealed even newer
facets of this versatile protein. While its function as an ion-pump is vital, NKA also serves as a
non-enzymatic receptor independent of its enzymatic function that inhibits Na+ transport through
interdependent inhibition of NKA and NHE3 in RPT, and shows promise as a salt-sensor in
RPT-mediated regulation of systemic sodium and volume homeostasis. Thus, based on the
current evidence, RPT NKA simultaneously serves two critical and opposing roles in Na+
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reabsorption: anti-natriuretic through its classic ATPase-driven ion transport function, and
natriuretic through its more recently recognized receptor/signaling function. To date, the relative
contributions of these two NKA functions to the net Na+ reabsorption by RPT remains a
fundamentally and therapeutically essential question that has been challenging to answer.
Translationally, a clarification of the RPT NKA signaling in Na+ overload and salt sensitivity
could open a new field of pathophysiological and pharmacological studies and pave the way for
novel therapeutics targeting hypertension. Therefore, to address the crucial research question of
physiological relevance of NKA non-enzymatic function in RPT Na+ transport, we performed an
array of studies in genetically modified renal cells and mice with RPT-specific alteration of NKA
α1.
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Abstract
Active ion transport by Na/K-ATPase (NKA) drives the transcellular reuptake of Na+ in
the renal proximal tubule (RPT). In addition, NKA has a Src kinase-dependent signaling function
that downregulates Na+ reuptake by other RPT ion transporters. To establish the importance of
this dual function on Na+ and water homeostasis, we examined the effect of genetic
downregulation of NKA expression in RPT in vitro and in vivo. Silencing NKA in RPT cell
monolayers resulted in a doubling of Na+ transport, without increase in paracellular transport.
Genetic suppression of RPT NKA in mice increased renal Na+ absorption and markedly
decreased daily urinary Na+ and water excretion. These effects were attributable to the
dismantling of the NKA-Src signaling axis, through uncoupling and redistribution of Src, which
leads to unregulated plasmalemmal ion transporters. Hence, RPT NKA signaling is not only
physiologically important, but predominates over the enzymatic function of NKA in the
regulation of RPT Na+ absorption
Introduction
The mammalian kidney maintains extracellular homeostasis amidst large
qualitative and quantitative variations in dietary intake of solutes and water by processing >20%
of the cardiac output every minute. Two-thirds of the ﬁltered sodium, potassium, chloride,
bicarbonate, phosphate, and water, as well as virtually all the ﬁltered glucose and amino acids,
are reabsorbed in the renal proximal tubule (RPT). Adequate modification of bulk absorption of
salt and water in the RPT in response to physiological stimuli (e.g. increased renal perfusion
pressure, high salt diet) is an independent determinant of blood pressure (BP), and is therefore
highly consequential clinically (Joe & Shapiro, 2012; McDonough, 2010a; McDonough &
Nguyen, 2015).
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In the RPT, as in all Na+-absorbing epithelia, Na/K-ATPase (NKA) is exclusively
located in the basolateral membrane. In the renal nephron, the peritubular Na+ gradient generated
by NKA, which operates only at 20-30% of its maximum rate under basal conditions, is
primarily dissipated by apical membrane transporters (Cheval & Doucet, 1990). This
architectural organization results in a net transfer of Na+ from the nephron lumen toward the
interstitial space. The apical Na+/H+-exchanger-3 (NHE3, Slc9a3) mediates 80% of luminal Na+
intake in the RPT, which is primarily coupled to H+ extrusion, and secondarily linked to
bicarbonate absorption. The basolateral Na+/HCO3- cotransporter (NBCe1A, Slc4a4A), which
transports all of the filtered bicarbonate, is directly coupled to Na+ (Kurtz & Zhu, 2013; Sciortino
& Romero, 1999).
To adjust Na+ transport to physiological demand, apical Na+ entry (NHE3),
basolateral Na+ exit (NKA and NBCe1A), or both, can be quickly modulated through posttranslational mechanisms that include modulation of their transport properties and cellular
redistribution. Regulatory pathways described to date suggest that apical and basolateral Na+
transport systems are modulated through concerted but independent mechanisms (Féraille &
Doucet, 2001; M. C. Hu et al., 2001; Kunimi et al., 2000; McDonough, 2010a; McKinney &
Myers, 1980; Pedemonte et al., 2005b; Y. Zhang et al., 1999). For example, the natriuretic
hormones dopamine and parathyroid hormone stimulate parallel PKC-mediated inhibition of
NKA and cAMP-dependent inhibition of NHE3 and NBCe1A to decrease RPT Na+ absorption
(Aperia et al., 1987; Kunimi et al., 2000; McKinney & Myers, 1980; Pedemonte, Efendiev, &
Bertorello, 2005a; Y. Zhang et al., 1999). An advantage of a concerted parallel control of Na+
transporters is that it minimizes variations in intracellular ion concentrations, pH or cell volume
that would otherwise alter numerous cellular functions.
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In contrast, inhibition of RPT Na+ absorption by the specific NKA ligands
cardiotonic steroids (CTS) is a NKA/NHE3 coupled regulatory mechanism. Importantly, this
regulatory mechanism is distinct from the natriuretic and diuretic effects observed in response to
high concentrations of CTS, which cause a substantial (and physiologically irrelevant) inhibition
of the basolateral absorption of Na+ by NKA (Eliades, Pamnani, Swindall, & Haddy, 1991;
Hook, 1969; Nechay, 1974). Rather, the NKA/NHE3 coupling operates at much lower
concentration of CTS, and within the CTS range reported in human plasma, which makes this
system physiologically relevant (Hamlyn & Blaustein, 2016; Hamlyn et al., 1991). Thus,
circulating levels of CTS acutely downregulate apical NHE3 through a mechanism that is not
associated with a sustained measurable change in intracellular [Na+], but requires NKA
redistribution to the intracellular membrane compartment prior to NHE3 internalization (ArnaudBatista et al., 2012; H. Cai et al., 2008; Godinho et al., 2017; Yan et al., 2012). In vitro
approaches exploiting well-known inter-species differences in NKA affinity for CTS have
suggested that basolateral RPT NKA α1 is the isoform that mediates CTS-induced NHE3
distribution and inhibition of apical Na+ influx (Loreaux et al., 2008; Yan et al., 2012). Those
studies also suggest that the mechanism is Src-dependent, which is consistent with the CTSinduced activation of NKA α1/Src receptor mechanism.
This proposed NKA/NHE3 coupling mechanism could have far-reaching fundamental
physiological and clinical ramifications, as it establishes a NKA-based mechanism for the
regulation of RPT apical Na+ absorption by CTS and non-CTS modulators of NKA, which has
remained unexplored. Unfortunately, experimental limitations have hampered progress in this
line of research to date. First and foremost, the observation that the proposed signaling
mechanism can occur without measurable inhibition of NKA enzymatic activity limits the impact
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of pharmacological approaches. As a result, it has been challenging to firmly establish NKA α1
as the molecular machinery that couples the exposure to low concentration of CTS to NHE3
inhibition. The need for a definitive demonstration has been further accentuated by recent studies
that have challenged the classically recognized role of NKA as the specific receptor and
mechanism of action of CTS (Arnaud-Batista et al., 2012; Banerjee et al., 2018; H. Cai et al.,
2008; Godinho et al., 2017; Z. Li et al., 2009; Liu et al., 2002; Yan et al., 2012). Further, given
the ubiquitous expression of NKA α1 and the systemic distribution of endogenous CTS, a
specific functional impact on RPT Na+ absorption has also been difficult to evaluate. Finally,
NKA coupling to RPT Na+ transporters other than NHE3 has not been explored.
To address those critical issues and establish the importance of NKA non-ion pumping
function in RPT Na+ handling, we used a genetic approach to suppress Atp1a1, the gene that
encodes the α1 isoform of NKA, in RPT cells and in RPT-specific mouse models. Our findings
are consistent with a model whereby NKA signaling exerts a tonic inhibition on Na+ absorption
by regulating key apical and basolateral Na+ transporters. This action, which is lifted upon NKA
genetic suppression in cells and in vivo, tonically counteracts the classic NKA enzymatic
function. Strikingly, NKA/Src signaling is not only physiologically relevant, it is functionally
dominant over NKA ion-pumping in the control of RPT Na+ absorption. NKA signaling
therefore provides a long sought-after mechanism for the natriuretic action of endogenous NKA
ligands such as CTS.
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Results
Knockdown of 90% NKA α1 redistributes key apical and basolateral Na+
transporters and increases transepithelial Na+ flux.
To assess the contribution of NKA signaling vs. NKA classic ion-pumping role in the
regulation of transepithelial Na+ transport, we used the PY-17 cell model. This model is derived
from the porcine renal epithelial cell line LLC-PK1 and is the only mammalian cell system with
a 90% knockdown of NKA α1, which is the only NKA α-isoform expressed in renal epithelial
cells (Man Liang et al., 2006). Our initial characterization of PY-17 has shown that those cells
lose 60% of cellular NKA enzymatic activity, which results in increased intracellular Na +
concentration. Those studies also showed that signaling by the caveolar NKA signaling complex
is lost in PY-17 (Man Liang et al., 2006; Man Liang et al., 2007). This was evidenced by a
dysregulation of Src and other NKA signaling partners, an inability to activate in response to the
CTS ouabain, and an abnormal cellular distribution of the protein partners (T. Cai et al., 2008;
Yiliang Chen et al., 2009; Ying Chen et al., 2008; Man Liang et al., 2006).
In the present study, LLC-PK1 and PY-17 monolayers were grown on transwell
membrane inserts. As shown in Figure 5A, total transepithelial 22Na+ flux was doubled in PY-17
cells. We also observed that transepithelial electrical resistance (TER) was significantly
increased in PY-17, excluding increased paracellular permeability as the mechanism for
increased transepithelial Na+ flux (Figure 5B). Western blot analysis confirmed the expected
minimal expression of NKA α1 in PY-17 cells (Figures 5C-D), and further revealed that total
NHE3 was unchanged (Figures 5C, 5F). This set of studies also revealed that phosphorylation of
NHE3 at Ser552 (which mediates NHE3 internalization and inactivation (Kocinsky, Dynia,
Wang, & Aronson, 2007; Kurashima et al., 1997)) was decreased by 50% (Figures 5C, 5E),
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indicative of an increase in active membrane NHE3. Moreover, expression of the basolateral
NBCe1A, the other major route of Na+ efflux in RPT cells, was also significantly increased in
PY-17 (Figures 5C, 5G). The higher transcellular Na+ flux, activation of NHE3, and the
upregulation of expression of NBCe1A upon genetic suppression of NKA α1 in PY-17 is
consistent with the existence of a NKA-dependent mechanism that tonically tempers
transcellular Na+ influx in the RPT cells and therefore counteracts the NKA transport driven
function that generates the steep transcellular Na+ gradient.

Figure 5: Genetic ablation of 90% of NKA 1 in renal epithelial cells leads to increased
transepithelial Na+ transport, decreased phosphorylation(ser552)-mediated inactivation of
NHE3, and increased total NBCe1A.
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(A) Transepithelial 22Na-flux (relative to average of control LLC-PK1 cells) and (B)
Transepithelial Electrical Resistance (TER) were measured in polarized monolayers of NKA
knockdown (PY-17) or parental wild type LLC-PK1 cells. Representative films from western
blots for NKA 1, phosphoser552-NHE3, total NHE3, and total NBCe1A and their respective
quantitation (C-G). All quantifications were normalized to α-tubulin followed by normalization
to average of control values per gel. Results are presented as mean ± SEM and data were
analyzed by t-test. *p< 0.05 and ***p<0.001 versus LLC-PK1.
Genetic targeting of RPT NKA α1 in the mouse.
We generated floxed Atp1a1 mice, designed to have exons 15-18 excised when crossed
with a Cre mouse. The strategy of removing exons 15-18, summarized in Figure 6A, was
selected to 1) disrupt the transmembrane loop between TM4-TM5, which is vital for ATPase
activity and Src interaction, and 2) cause a frameshift leading to nonsense mRNA-mediated
decay. The floxed Atp1a1 mouse was crossed with the Na+/glucose cotransporter 2-Cre mouse
(SGLT2-Cre) (Rubera et al., 2004). Homozygous (RPTα1-/-) mice were viable. Body weight,
food consumption, water intake, and body composition were not modified (Table 2). Western
blot analysis indicated a decrease of about ~40% in total NKA 1 expression in renal cortex
relative to RPT1+/+ (control) littermates (Figures 7A-B), but not in the medulla (Figures 7C-D).
To verify that this cortical decrease of NKA expression was exclusively attributable to the RPT,
histological preparations were analyzed by immunofluorescence. As shown in Figure 7E, renal
cortices stained with villin-1, a microvillar actin bundling protein specifically expressed in the
RPT (magenta) and NKA α1 (red) were obtained from 4-month old males RPT α1+/+ and RPT
α1-/- mice. Quantitative analyses revealed a significant and specific decrease of 70% of NKA
signal in the RPT of RPT1-/- mice (Figures 7E-F).
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Figure 6: Proximal tubule-specific Atp1a1 ablation.
(A) Scheme for generation of RPT-specific Atp1a1 knockout mouse model using a Cre/Lox
approach. DNA genotyping for homozygous floxed NKA α1 (B) and heterozygous SGLT2-Cre
(C). Mice positive for homozygous floxed α1 and heterozygous SGLT2-Cre were grouped as
RPTα1-/- and mice positive for homozygous floxed α1 but negative for SGLT2-Cre were grouped
as controls RPTα1+/+. (D-E) Representative blots of NKA α2 and α3 in RPTα1-/- and RPTα1+/+
cortex with control mouse brain used as positive control (4-month male).
There was no compensatory expression of alternate NKA α-isoforms, 2 and 3,
detected in kidney homogenates (Figures 6D-E). Such robust yet not complete reduction of RPT
NKA 1 was not unexpected, since SGLT2 is only expressed in the S1 (major) and S2 (minor)
segments. Additionally, SGLT2-Cre has been reported to produce a robust but not complete
ablation of RPT transporters (H. C. Li et al., 2013). Hence, the RPTα1-/- mouse is a hypomorphic
model with NKA α1 expression reduced to 30% in the RPT. Kidney histological analysis after
periodic acid schiff (PAS) staining and hematoxylin and eosin (H&E) staining did not reveal any
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gross structural alteration (Figures 8A-F). Glomerular number and area, RPT area, and number
of cells per RPT in RPT1-/- were comparable to those in control littermates (Figures 8A-E).
RPTα1+/+
28±1
7±0.4
7±0.4

RPTα1-/28±1
7±0.3
7±0.5

Body Weight (g)
Daily water intake (g)
Daily food intake (g)
Body Composition:
Fat (g)
2.1±0.5
2.7±1
Lean (g)
25±1
24±1
Total Water (g)
21±1
20±1
Free Water (g)
0.21±0.05
0.16±0.02
Table 2: Basal metabolic characteristics and Body Composition Analysis by EchoMRI.
Values are mean ± SEM for n=10-12 (Metabolic Cage) and n=5-6 (EchoMRI) for 4-month male
and female (1:1) mice. No significant difference was observed by Student’s t-test.

Figure 7: NKA α1 expression in the RPT α1 hypomorphic mouse.
Representative western blots and quantification of NKA α1 in renal cortex homogenates from
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RPTα1-/- and RPTα1+/+ control mice (A-B). Representative western blots and quantification of
NKA α1 in renal medulla homogenates from RPTα1-/- and RPTα1+/+ control mice (C-D). All
quantifications were normalized to α-tubulin followed by normalization to the average of control
values in each gel. Representative immunostaining of RPT for NKA α1 (red), RPT brush-border
marker Villin-1(purple), in kidney cross-section and quantitation of NKA α1 in villin-1-stained
RPT (n=5) for RPTα1-/- and RPTα1+/+(E-F). Scale bar: 50 µm. Adult 4-month male RPTα1-/and RPTα1+/+ controls were used. Results are presented as mean±SEM and data were analyzed
by t-test. *p< 0.05, ***p<0.001 versus RPTα1+/+.

Figure 8: Morphometric and Histological Analysis of Kidney cross-sections by Periodic
Acid Schiff and Masson’s Trichrome staining in RPTα1-/-.
(A-B) Number and average area of glomerulus per cross-section in RPTα1-/-. (C-D) Average area
and number of cells per proximal tubule per cross-section in RPTα1-/-. (E-F) Representative
images from PAS-stained and Masson’s Trichrome stained cross-sections of kidney from
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RPTα1-/- compared to RPTα1+/+. Values are mean ± SEM and data were analyzed by Student’s ttest. No significance difference was observed.
Increased Na+ absorption in the hypomorphic RPT1-/- mouse.
To test whether the hypomorphic RPTα1-/- mouse has a hyper-absorptive renal phenotype
as predicted by our observations in PY-17 cells (Figure 5), a functional evaluation was
performed in 4-month-old males and females. Mice were acclimated for 24h in metabolic cages
prior to 24h of urine collection to determine daily urine and Na+ output, and to analyze urine
chemistry. As shown in Figures 9A-B and 10A-B, a robust and significant decrease of over 65%
in daily urinary output and daily absolute Na+ excretion was observed in the RPTα1-/- mouse of
both sexes. SGLT2-Cre mice exhibited no change in body weight, water and food intake, or daily
urine output (Table 3).

Body Weight (g)

Control
28.4±0.7

SGLT2-Cre
28.5±0.1

Daily water intake (g)

6.7±0.2

6.9±0.9

Daily food intake (g)
Daily Urine Output (mL)

5.1±0.2
1.7±0.1

4.7±0.2
1.9±0.4

Table 3: Basal metabolic characteristics of SGLT2-Cre mice.
Values are mean ± SEM for n=3 4-month male mice. No significant difference was observed by
Student’s t-test.
Since this decrease in urinary excretion was not associated to a parallel increase in body
mass over the course of the study (Figure 10C), we investigated water excretion through other
measurable known routes of excretion in mice. As shown in Figures 10D-F, those studies
revealed that water loss through expired air and fecal matter compensated for the decreased loss
through urine in RPTα1-/- mice.
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Given the high reliance on RPT Na+ transporters for Na+ handling in males relative to
females (Veiras et al., 2017), the following set of studies characterizes RPT function in males
and excludes females to limit confounding factors due to sexual dimorphism. Serum and urine
chemistry panels, including blood urea nitrogen (BUN), albumin and creatinine (Tables 4&5) did
not indicate that glomerular and/or tubular dysfunction was associated to this drastic reduction of
diuresis in RPT1-/- male mice, which is consistent with normal renal morphology and histology
reported in Figure 8. Despite the substantial decrease in diuresis, urine chemistry values were
within the normal range in RPT1-/- mice. The panel presented in Table 4 indicated an absence
of change in urinary concentrations for most electrolytes (Na+, K+, Cl-, and Ca2+), with modest
but significant decreases in urine pH and glucosuria detailed in the next paragraph (Table 4).
Remarkably, although excretion was drastically reduced, blood homeostasis for all metabolites
and electrolytes tested (Table 5), along with glucose and insulin tolerance (Figures 10G-J)
remained unchanged in RPT1-/- mice.
The glomerular filtration rate (GFR), measured by determining FITC-sinistrin clearance,
was unchanged in RPT1-/- mice (Figures 9C-D). On the other hand, RPTα1-/- exhibited reduced
hematocrit (45.9±0.8% vs 48.5±0.5 in RPTα1+/+), a 40% decrease in serum aldosterone, and a
40% increase in serum atrial natriuretic peptide levels (Figures 9E-G), which are generally
observed in mice under increased systemic sodium levels and increased blood pressure (Graudal,
Hubeck-Graudal, & Jürgens, 2012; Loreaux et al., 2008; Merrill, Ebert, Skelton, & Cowley Jr,
1989; Simchon et al., 1989; Yatabe et al., 2010). Hence, although extra-renal excretion routes
(including expired air and fecal) appear to provide a remarkably efficient compensatory
mechanism to allow the 4-month-old RPT1-/- mouse to maintain homeostasis under basal
laboratory conditions, early manifestation of sodium overload is present in those animals.
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Figure 9: Renal sodium handling in RPTα1-/-.
Four-month-old male and female mice were used in a 1:1 ratio to assess daily urine output (A)
and absolute Na+ excretion (UNa+V) expressed as UNa+V = Urine [Na+] (mmol/mL) x Urine
volume (mL/24h) (B). Transcutaneous measurement of FITC-sinistrin clearance t1/2 in 4-month
old male mice, used to calculate GFR (µL/min), is shown normalized to mouse body weight.
GFR (µL/min) = (14616.8/FITC-Sinistrin t1/2)*BW/100 (C-D). Serum aldosterone (E), Serum
atrial natriuretic peptide (ANP) (F), Hematocrit (G) in 4-month-old male mice of the indicated
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genotype. Results are presented as mean ± SEM. Data were analyzed by t-test. *p < 0.05,
**p<0.01, and ****p<0.0001 versus RPTα1+/+

Figure 10: Urine and Na+ output, Water excretion through alternate routes and Glucose
and Insulin tolerance tests in RPTα1-/-.
Daily urine output (A) and Absolute Na+ excretion (UNa+V) expressed as UNa+V = Urine [Na+]
(mmol/mL) x Urine volume (mL/24h) (B) in male and female RPTα1-/- and controls. (C) Body
weight measured during 48hr metabolic cage analysis of RPTα1-/- and controls (M for Males and
F for Females) (D) Fecal water loss measured by 72hrs drying of feces collected by metabolic
cage. (E) Respiratory water loss measured as exhaled breath condensate (EBC). (F)Total water
loss through urine (orange), fecal (purple), and respiratory (green) in RPTα1-/- (n=4-7, 4-month
male and female) (G-H) Glucose tolerance test curve and the quantitation of area under the curve
(n=10-14, 4-month male) (I-J) Insulin tolerance test curve tolerance test curve and the
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quantitation of area under the curve (n=5-6, 4-month male). Values are mean ± SEM and data
were analyzed by one-way ANOVA with a Tukey multiple comparisons test (A-C) or Student’s
t-test (D-J). **p<0.01, ***p<0.005 vs RPTα1+/+, blue **<p0.001 vs Male RPTα1+/+, and pink
*p<0.05 and **<p0.001 vs Female RPTα1+/+.

Sodium (mEq/L)
Potassium (mEq/L)
Chloride (mEq/L)
Creatinine (mg/dL)
Phosphorus (mg/dL)
Calcium (mg/dL)
Magnesium (mg/dL)
Glucose (mg/dL)
pH

RPTα1+/+
217±10, n=11
413±30, n=8
300±20, n=11
53±3, n=12
159±20, n=12
21±4, n=5
48±7, n=7
127±20, n=7
6.4±0.1, n=7

RPTα1-/202±20, n=9
346±50, n=6
290±30, n=9
53±5, n=10
135±10, n=9
14±5, n=6
60±7, n=6
72±10*, n=6
6.1±0.05*, n=7

Table 4: Urine chemistry panel of RPTα1-/- and control RPTα1+/+ mice.
Values are mean±SEM in 4-month male mice. *p<0.05 vs RPTα1+/+.

Sodium (mEq/L)
Potassium (mEq/L)
Chloride (mEq/L)
Creatinine (mg/dL)
Phosphorus (mg/dL)
Calcium (mg/dL)
Fasting glucose (mg/dL)
Albumin(g/dL)
BUN (mg/dL)
Total protein (g/dL)

RPTα1+/+
148±1
5.07±0.1
118±1
0.12±0.04
8.2±1
8.8±0.3
131±7
2.4±0.1
39±4
4.6±0.2

RPTα1-/148±2
4.86±0.1
116±2
0.14±0.04
9.3±1
8.9±0.2
128±10
2.4±0.1
36±6
4.5±0.2

Table 5: Serum chemistry panel of RPTα1-/- and control.
Values are means±SEM in 4-month male mice (n=5-6/genotype). No significant difference was
observed.
Increased RPT Na+ absorption and upregulation of Na+ transporters in the RPT1-/mouse mirror the in vitro mechanism.
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The reduction of natriuresis following NKA reduction in the RPT S1/S2 segments of the
RPT1-/- mouse is consistent with a reduced absorption of Na+ by the RPT. Although it is at
odds with the phenotype solely predicted based on NKA enzymatic function (less basolateral
NKA ion-pumping should decrease Na+ absorption by the RPT), it is consistent with the
predicted phenotype based on a model that includes NKA signaling function (less basolateral
NKA signaling should increase NHE3-mediated absorption). In fact, the net increase in Na+
absorption upon NKA suppression suggests that signaling is functionally dominant under
physiological conditions. Remarkably, this was also predicted by the increased transcellular Na +
flux in RPT cells with genetic suppression of NKA in PY-17 (Figure 5). Consequently, we set
out to test this hypothesis by assessing whether 1) cellular redistribution of apical and basolateral
Na+ transporters occur in the RPT of RPT1-/- mice as observed in PY-17 and 2) whether those
changes are associated with functional evidence of hyper-absorption in the RPT of the RPT1-/mouse.
As shown in Figures 11A-C, a significant decrease of over 50% in NHE3
phosphorylation at Ser-552 without change in total NHE3 was observed by western blot in the
renal cortex of RPT1-/- mice. As predicted by decreased phosphorylation of NHE3 (i.e.,
decreased inactivation), a 2-fold increase in membrane expression of NHE3 was also detected
(Figures 11D, 11F). This cellular redistribution of NHE3 was accompanied by a 60% decrease in
urine lithium clearance and decreased serum lithium clearance in RPT1-/- mice (Figures 11G-I).
The proposed molecular mechanism implies a causative link between RPT NHE3 redistribution
to the apical membrane and increased absorption in the RPT1-/- mouse. Specifically, that NHE3
activation drives increased Na+ absorption in the RPT upon removal of 70% of RPT NKA.
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Consistent with this model, the hyper-absorptive phenotype of the RPT1-/- mouse was
not observed in the double RPT1-/-/RPTNHE3-/- mouse obtained by crossing RPT1-/- with
Floxed NHE3 mice (H. C. Li et al., 2013; X. C. Li et al., 2018), using the strategy shown in
Figure 12A. Like RPT1+/+NHE3+/+, RPT1-/-NHE3-/- mice were born with the expected
Mendelian frequency and equal male: female ratio. They had no gross change in appearance,
body weight, or food and water intake (Table 6), and the expected drastic reduction of NHE3 and
NKA was observed by western blot in renal cortex homogenates (Figures 12E-G) but not in renal
medulla homogenates (Figures 12H-J). As shown in Figures 11J-K, urine volume and urinary
Na+ content were significantly greater in the RPTα1-/-NHE3-/- mice compared to the RPTα1-/mice, undistinguishable from their control littermates with normal expression of NKA and NHE3
(RPTα1+/+NHE3+/+).
In addition to NHE3 modulation, a 2-fold increase in NBCe1A membrane expression was
detected in the RPT1-/- renal cortex (Figures 11E-F). This increase is consistent with the
increased expression noted in the PY-17 model (Figure 5), but perhaps more importantly it is
corroborated functionally by a modest but significant decrease in urine pH detected in RPT1-/(Table 4). Indeed, a decreased urine pH is predicted by the combined increase of apical NHE3
(increased H+ excretion) and basolateral NBCe1A (increased NaHCO 3 absorption). A
significantly decreased glucosuria (Table 4), still within the normal range of values reported for
laboratory mice (Green, 1966) but unexpected given the already reduced glucose excretion in the
RPT1-/- mouse, was further indicative of a possible direct or indirect effect on apical
Na+/glucose co-transporter 2 (SGLT2, Slc5a2).
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Figure 11: RPT sodium transporters and sodium reabsorption in RPTα1-/-.
Protein expression and corresponding representative film from western blots for phosphoser552NHE3 and total NHE3 in RPTα1+/+ and RPTα1-/- mouse renal cortex homogenates. All
quantifications were normalized to α-tubulin followed by normalization to average of control
values(A-C). Protein expression and corresponding representative films from Western blots for
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NHE3 and NBCe1A in membranes isolated from renal cortex of RPTα1+/+ and RPTα1-/- mouse
kidneys All quantifications were normalized to E-Cadherin (membrane protein marker) followed
by normalization to average of control values (D-F). Urine Lithium clearance as a functional
marker for RPT Na+ reabsorption function in 4-month male mice of the indicated genotype
(n=11-14) (G). (H-I) Serum lithium clearance curve and quantification of area under curve
(AUC). Curve and AUC normalized to peak dose in serum measured at 1hr (n=6-8, 4-month
male). (J) Daily urine output measured in 4-month male mice using metabolic cage and (K)
Absolute Na+ excretion (UNa+V) RPTα1-/-NHE3-/- mice compared to RPTα1-/- and controls
(RPTα1+/+NHE3+/+). UNa+V = Urine [Na+] (mmol/mL) x Urine volume (mL/24h). Results are
presented as mean ±SEM and data were analyzed by t-test (A-I) or one-way ANOVA with a
Tukey multiple comparisons test (J-K). *p<0.05, **<p<0.01, and ***p<0.001 vs RPTα1+/+or
RPTα1+/+NHE3+/+, ### p<0.001 vs RPTα1-/-NHE3-/-.

Body Weight (g)
Daily water intake (g)
Daily food intake (g)

RPTα1+/+NHE3+/+
31.1 ± 1
7.3 ± 0.5
5.35 ± 0.4

RPTα1-/-NHE3-/32.5 ± 0.9
6.6 ± 0.2
4.92 ± 0.2

Table 6: Basal metabolic characteristics of RPTα1-/-NHE3-/-mice.
Values are mean±SEM for 4-month male mice (n=6-7/genotype). No significant difference was
observed by Student’s t-test.
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Figure 12: Proximal-tubule specific Atp1a1 and NHE3 ablation.
Scheme for generation of RPT-specific ablation of Atp1a1 and NHE3 in mouse using Cre/Lox
system (A). DNA genotyping for homozygous floxed NKA α1 (B), homozygous floxed NHE3
(C), and heterozygous SGLT2-Cre (D). Mice positive for homozygous floxed α1 and
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homozygous floxed NHE3 and heterozygous SGLT2-Cre were grouped as RPTα1-/-NHE3-/- and
mice positive for homozygous floxed α1 and homozygous floxed NHE3 but negative for
SGLT2-Cre were grouped as controls RPTα1+/+NHE3+/+. Representative western blots and
quantification of NKA α1 and NHE3 in renal cortex homogenates from RPTα1-/-NHE3-/- and
RPTα1+/+NHE3+/+ control mice (E-G). Representative western blots and quantification of NKA
α1 and NHE3 in renal medulla homogenates from RPTα1-/-NHE3-/- and RPTα1+/+NHE3+/+
control mice (H-J). All quantifications were normalized to α-tubulin followed by normalization
to the average of control values in each gel. Values are mean ±SEM and data were analyzed by
Student’s t-test. **p<0.01, ***p<0.001 vs RPTα1+/+NHE3+/+
Dysregulation of Src kinase in the proximal tubules of the hypomorphic RPTα1-/mouse.
We next turned our attention to the underlying signaling mechanism that could modulate
Na+ absorption. Regulation of NHE3 and Na+ influx in RPT cells by CTS has been shown to be
Src-dependent (H. Cai et al., 2008; Godinho et al., 2017; Liu et al., 2011; Yan et al., 2012). CTS
are widely viewed as specific ligands of NKA, which suggests that disruption of the NKA α1/Src
receptor mechanism, as first described by Z. Xie (Haas et al., 2000; Haas et al., 2002; Man Liang
et al., 2006; Tian et al., 2006; Z. Xie, 2003), could be the critical event that led to
NHE3/NBCe1A activation and subsequent decrease in urine excretion.
Consistent with this hypothesis, sucrose-density-based cellular fractionation studies
revealed a significant redistribution of residual NKA α1 and Src kinase outside the light
caveolar-rich domains in the renal cortex of RPT1-/- mice (Figures 13A-B), akin to the
redistribution observed in PY-17 cells (Figures 13C-D). Using triple immunofluorescence
labeling in renal cortical sections (villin: magenta; phosphoTyr419Src: green; NKA: red), we
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further observed a diffuse intracellular signal for activated phosphoTyr419Src in villin-positive
RPT1-/- tubules with reduced colocalization of phosphoTyr419Src with NKA (Pearson’s
correlation coefficient, PCC=-0.05±0.03 vs 0.4±0.02 in RPT1+/+) which markedly differed from
its clustered membrane distribution in RPT1+/+ (Figure 13E). For comparison, immunolabeling
of NKA (red) and phosphoTyr419Src (green) was performed in parental (LLC-PK1) and NKA
knockdown (PY-17) pig RPT cells. As shown in Figure 13F, a diffuse intracellular redistribution
of phosphoTyr419Src away from the plasma membrane and decreased colocalization with
membrane NKA (PCC=0.5±0.03 vs 0.9±0.01 in LLC-PK1) and comparable to the redistribution
in the RPT1-/- was observed. Collectively, these observations support a role for NKA/Src
receptor complex in regulation of NHE3, NBCe1A and RPT Na+ transport.

Figure 13: Loss of NKA α1 leads to dismantlement of NKA/Src receptor complex in RPT
cells.
(A-B) Representative western blot for NKA α1, caveolin-1, and c-Src in caveolin-enriched
fractions (4/5) together with fractions 6-11 obtained after sucrose-density fractionation in renal
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cortex from RPTα1+/+ and RPTα1-/- and the respective quantitation of percentage of signals from
caveolin-enriched fraction against total signal. (C-D) Representative western blot for NKA α1,
caveolin-1, and c-Src in caveolin-enriched fractions (4/5) together with fractions 6-11 obtained
after sucrose-density fractionation in LLC-PK1 and PY-17 cells and the respective quantitation
of percentage of signals from caveolin-enriched fraction against total signal. (E) Representative
immunostaining for NKA α1 (red), phosphoTyr419-Src (green), villin-1(magenta) in kidney crosssections from RPTα1+/+ and RPTα1-/-. Scale bar: 25µm. (F) Representative immunostaining for
NKA α1 (red) and phosphoTyr419-Src (green) in LLC-PK1 and PY-17 cells. Scale bar: 25µm.
Results are presented as mean±SEM and data were analyzed by t-test. **p< 0.05 versus
RPTα1+/+ and ***p<0.001 versus LLC-PK1.
NKA α1/Src receptor function causes tonic inhibition of NHE3 and NBCe1A.
To functionally challenge our hypothesis of NKA α1/Src-mediated tonic inhibition of
NHE3 and NBCe1A in RPT cells, we utilized a loss-of-function/gain-of-function approach. The
strategy was based on recent advances in our understanding of the structural basis of NKA/Src
receptor function and its NKA isoform-specificity. It relies on the fact that the two known critical
Src binding sites (the NaKtide sequence and Y260 (Banerjee et al., 2018; Lai et al., 2013; Z. Li
et al., 2009; Yu et al., 2018)) required for adequate NKA α1/Src-mediated signaling are specific
to the mammalian NKA α1 polypeptide sequence, the only NKA α isoform expressed in RPT
cells. Critically, the Y260 residue is absent in the NKA α2 isoform, which does not support Srcdependent signaling (Banerjee et al., 2018). Table 7 summarizes key features of the cell lines
used in the set of studies shown in Figure 14. All these lines were obtained by rescuing PY-17
cells with WT or selected mutant forms of rat NKA α1 or α2. The AAC-19 line, expressing the
WT rat NKA α1, was the Src-signaling-enabling control for the Y260A line, a Src-signaling-null
52

rat α1 mutant line (Table 7) (Banerjee et al., 2018; Lai et al., 2013; J. X. Xie et al., 2015; Yu et
al., 2018). In the reciprocal gain-of-function experiment, the LX-α2 line expressing WT rat NKA
α2 (Src-signaling null) was the control for LY-a2, a mutant rat α2 that was engineered to contain
both Src binding sites (Table 7). Importantly, enzymatic NKA activity was identical in all those
cell lines, which allowed direct comparison of Na+ transporter regulation.
When compared to AAC-19 cells, Y260A cells had a ~50% decrease in inhibitory ser552
phosphorylation of NHE3 and no change in total NHE3 (Figures 14A-B, 14D). Conversely, a
50% increase in phosphorylation-mediated inactivation and no change in total NHE3 was
observed in LY-a2 cells compared to LX-α2 (Figures 14E-F, 14H). Finally, total NBCe1A
expression was increased by 2-fold in Y260A cells compared to AAC-19 cells (Figures 14C-D),
and decreased by 2-fold in LY-a2 cells compared to LX-α2 cells (Figures 14G-H). Taken
together, these data indicated that NKA/Src signaling is required for tonic inhibition of NHE3
and NBCe1A by NKA α1.
Collectively, these results provide genetic evidence for tonic inhibition of RPT Na+
transport by NKA α1/Src receptor signaling in RPT cells. This novel regulatory pathway
physiologically counteracts NKA-dependent enzymatic Na+ absorption as summarized in Figure
15.
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NaKtide sequence

NKA/Src
signaling

NKA ionpumping
(% of
LLC-PK1)

Pig α1

253
RGIVVYTGDRT
263

413
SATWLALSRIAGLCNRAVFQ
432

Enabled

100

10% Pig
α1

253
RGIVVYTGDRT
263

413
SATWLALSRIAGLCNRAVFQ
432

Disabled

40

AAC-19

Rat α1

255
RGIVVYTGDRT
265

415
SATWFALSRIAGLCNRAVFQ
434

Enabled

100

Y260A

Mutant
Rat α1

255
RGIVVATGDRT
265

415
SATWFALSRIAGLCNRAVFQ
434

Disabled

100

LX-α2

Rat α2

253
RGIVIATGDRT
263

413
SPTWTALSRIAGLCNRAVFK
432

Disabled

100

LY-a2

Mutant
Rat α2

250
RGIVVYTGDRT
260

410
SATWFALSRIAGLCNRAVFQ
429

Enabled

100

Cell
Line

NKA
Isoform

Y260

LLCPK1

PY-17

Table 7: Amino acid sequences of the Src binding sites of the WT rat α1, loss-of-function
signaling mutant α1 NKA, WT rat α2, and gain-of-function signaling mutant α2 NKA
expressed by the AAC-19, Y260A, LX-α2, and LY-a2 cell lines.
Underlined letters indicate residues that have been changed in mutant α1 and α2, while bold
underlined letters indicate residues that differ from wild-type rat α1.
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Figure 14: Loss of Src-binding in NKA 1 reduces NHE3 inhibitory phosphorylation at
ser552 and increases NBCe1A in RPT cells.
Representative films from Western blots for phosphoser552-NHE3, NHE3 and NBCe1A with
respective quantification (A-C). AAC-19 (control) and Y260A, and (D-F) LX-2 and LY2
cells. All quantifications were normalized to α-tubulin followed by normalization to average of
control values. Results are presented as mean ± SEM and data were analyzed by Student’s t-test.
**p< 0.01, ***p<0.001 versus AAC-19 or versus LX-2.

Discussion
The renal proximal tubule is the center stage for physiological and pathological changes
associated with sodium balance and volume homeostasis. Distinctive architectural features and
cellular properties underlie unique regulatory responses of this highly permeable epithelium to
local and systemic cues. These regulatory mechanisms, some of which remain incompletely
understood, are considered of primordial importance for the understanding and management of
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hypertensive disorders (Joe & Shapiro, 2012; McDonough, 2010b; McDonough & Nguyen,
2015).
Using a genetic approach, the present studies uncovered a potent natriuretic pathway
controlled by a familiar ion pump in the RPT, the Na/K-ATPase (NKA). Arguably, NKA makes
quite an unlikely candidate as a molecular counteractor of Na+ absorption. In fact, NKA is
universally recognized as the very enzymatic machinery that drives avid absorption of Na+ along
the RPT (Figure 15A). With hindsight, it could also be argued that NKA has evolved as a
perfect molecular entity to sense intracellular Na+ and coordinate the cellular response to temper
absorption by the RPT. Indeed, we have learned that a Src-regulatory capability was acquired
selectively by the mammalian α1 isoform of the NKA’s catalytic subunit (Banerjee et al., 2015;
Man Liang et al., 2006; Madan et al., 2016; J. X. Xie et al., 2015; Yu et al., 2018).
Evidence in RPT cells have suggested that this NKA-centered mechanism downregulates
cell surface expression of apical NHE3 and basolateral NKA upon binding of a NKA ligand such
as the cardiotonic steroid (CTS) ouabain (H. Cai et al., 2008; Godinho et al., 2017; Liu et al.,
2004; Oweis et al., 2006; Yan et al., 2012). In the present study, genetic targeting of NKA in
RPT cells in vitro and in vivo further indicates that this NKA/Src mechanism also downregulates
the basolateral NBCe1A, which could be secondary to NHE3 reduction. To our knowledge, this
is the first description of a mechanism that links NKA, NHE3, and NBCe1A in an
interdependent pathway. It contrasts with regulatory pathways of RPT Na+ handling described to
date, which involve coordinated but independent regulation of NHE3, NBCe1A, and NKA [9,
59-61]. For example, the natriuretic hormones dopamine and parathyroid hormone have been
shown to stimulate parallel PKC-mediated inhibition of NKA and cAMP-dependent inhibition of
NHE3 and NBCe1A to decrease RPT Na+ absorption (Aperia et al., 1987; Kunimi et al., 2000;
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McKinney & Myers, 1980; Pedemonte et al., 2005b; Y. Zhang et al., 1999). Importantly, the
increase of NHE3/NBCe1A and transcellular Na+ in RPT cells monolayers indicates that the
NKA/Src-induced suppression of Na+ transporters exerts its effect tonically, and that this tonic
inhibition is lifted upon genetic suppression (Figure 5) or loss-of-function mutation (Figure 14).
As shown in Figure 15, we propose that NKA/Src provides a regulatory mechanism to temper
NKA-driven transcellular Na+ absorption and is activated by CTS.
The fundamental role of this NKA/Src mechanism was revealed by the hyper-absorptive
phenotype of the hypomorphic RPTα1-/- mouse. With no morphological or biochemical
indication of renal failure, and no indication of change in the GFR, a striking characteristic in
this model was that oliguria was not associated with major changes in blood or urine
composition. Consequently, and although extra-renal routes of fluid excretion provided a
remarkably efficient compensatory mechanism, evidence of systemic sodium loading and
extracellular volume expansion were noted, including decreased serum aldosterone and a
reduced hematocrit. Hence, with 2/3 of NKA units depleted and an overall neuro-hormonal
status favoring further reduction of NKA-mediated Na+ absorption, the RPT of the RPT α1-/mouse still reabsorbed copious amounts of Na+. This is consistent with the hypothesis that
NKA/Src signaling leads to a loss of intracellular Na+ sensing in the RPT, which in turn leads to
an aberrant absorptive response. Indeed, it has been suspected for decades that intracellular Na +
modulates the response to natriuretic and anti-natriuretic hormones in the RPT as the first step
mechanism to control Na+ absorption (Efendiev et al., 2003). As an example, dopamine-induced
inhibition of NKA ion transport function in RPT cells is sensitized by increased intracellular Na+
concentrations (Efendiev et al., 2003). The NKA/Src dependent signaling is NKA conformationdependent (Ye et al., 2013; Ye et al., 2011), and therefore a viable Na+ sensor to
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sensitize/desensitize RPT response to natriuretic and anti-natriuretic modulators. This sensor
may also play a role in the relatively low sensitivity of RPT Na+ absorption to hormonal signals
in response to changes in dietary Na+ compared to other nephron segments, and consequently
maintain a steady delivery of Na+ to the distal tubule regardless of dietary intake in the healthy
kidney (Ellison, Velazquez, & Wright, 1989; Malnic, Klose, & Giebisch, 1966; Palmer &
Schnermann, 2015; Vallon et al., 2002).
The RPT NKA/Src mechanism uncovered by this genetic approach provides a long
sought-after receptor mechanism to explain the natriuretic effect of endogenous CTS, which has
first been proposed more than 50 years ago. Endogenous CTS, then referred to as ‘third factor’,
were first identified as a crucial regulatory natriuretic factor by DeWardner (De Wardener, 1961;
De Wardener et al., 1971) and later isolated from circulating human plasma at subnanomolar
concentrations (Hamlyn et al., 1991). Their mechanism of action has remained debated,
particularly their action on NKA, as those concentrations are well below the concentration
necessary to inhibit the enzymatic NKA ion pumping activity (Liu et al., 2002). Further, the
ubiquitous expression of NKA α1 has made it difficult to assign CTS effects to a specific organ
system. Nonetheless, the first genetic evidence for a physiological role of endogenous CTS came
from an elegant study of the Lingrel lab, in which increased affinity of NKA α1 in mice led to an
increased natriuretic response and decreased Na+ absorption without change in GFR in response
to acute saline load (Loreaux et al., 2008). Our observations in the RPTα1-/- are consistent with
these findings, and further suggest that renal NKA α1/Src is the necessary and sufficient receptor
mechanism that mediates CTS-induced natriuresis.
This has significant clinical implications. Indeed, increased levels of endogenous CTS
have been reported in conditions such as volume expansion, pre-eclampsia, essential
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hypertension, primary aldosteronism, and end-stage renal disease (Bagrov et al., 1995; Bagrov &
Shapiro, 2008; Fridman et al., 2002; Gonick et al., 1998; Lopatin et al., 1999). The ability of
CTS to cause vasoconstriction has led many to postulate that these hormones contribute to the
development of the hypertensive state, despite their natriuretic properties. In contrast,
experimental models have indicated that an intact diuretic response to CTS is important for low
salt sensitivity of blood pressure. For example, in RPT cells from Dahl salt-sensitive rats, CTSinduced coupled inhibition of NKA and NHE3 is impaired. This may support increased RPT Na+
absorption as observed in the RPTα1-/- mouse, and contribute to elevated blood pressure in these
rats (Liu et al., 2011). Likewise, in chronically NaCl-loaded Sprague-Dawley rats, renal
excretion of the CTS marinobufagenin (MBG) is significantly elevated, and anti-MBG antibody
reduce natriuresis and restore sodium pump activity in the renal cortex (Periyasamy et al., 2005).
Consistent with an effect of MBG on the RPT NKA α1/Src mechanism described in the present
study, it was shown that MBG exhibited its natriuretic effects via internalization of the sodium
pump in the RPT. Through RPT NKA/Src, endogenous CTS released during high salt conditions
may therefore favor the excretion of excessive salt and ultimately contribute to the maintenance
of normal BP. Our approach using tissue-specific genetic targeting of the NKA receptor may
serve as a tool to explore whether endogenous CTS, acting on renal NKA α1, are indeed a
positive factor in the defense against hypertension.
A few aspects of these findings will require additional investigations. Indeed, in addition
to revealing a potent NKA/Src natriuretic signaling in the RPT, the data suggest that the loss of
NKA pump activity allows NBCe1A to functionally assume the role of an “auxillary Na+ pump”
in the RPT. It should also be noted that our investigation primarily focused on RPT NHE3, NKA
and NBCe1A. Other RPT transporters such as SGLT2 and Na+/Pi cotransporter (NaPi2) may
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also be regulated by the NKA/Src network. In RPTα1-/- mice, a modest modulation of acid-base
balance and absorption of glucose was detected without significant effect on GTT or ITT under
basal conditions. This is consistent with compensatory mechanisms by other nephron segments,
but could lead to functional imbalances in disease stages. Additionally, the decreased diuresis
and natriuresis were noted in a cohort of 4-month-old RPT α1 mice that included males and
females in a 1:1 ratio. Additional studies were performed exclusively in males of that age group,
and we therefore cannot generalize all our findings to the female sex given the increasing
evidence of renal sexual dimorphism (R. Hu et al., 2020; Q. Li et al., 2018; Veiras et al., 2017).
Based on this study, a better understanding of the dual antagonistic roles of NKA in the
RPT has become increasingly important, as both clinical and experimental evidence suggests that
a dysregulation of RPT NKA function by CTS and other regulators of renal Na+ absorption may
occur in salt-sensitive hypertension.

Figure 15: Scheme depicting Classic vs Dual function of NKA in RPT Na+ reabsorption and
corresponding predicted phenotype of the hypomorphic RPT1-/- mouse.
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The classical role of basolateral NKA in RPT Na+ transport is that of solely an enzymatic ionpump that drives the Na+ gradient and transport. Apical transporter NHE3 is the major route for
Na+ reabsorption in the RPT, with basolateral NBCe1A playing a more modest role (A). Based
on this classical role, a knockdown of NKA 1 in RPT would be expected to result in hyporeabsorption of Na+ and water, and increased natriuresis and diuresis in the hypomorphic NKA
1 mice (B). According to the dual function model of NKA, NKA/Src receptor-mediated
signaling plays a counteractive role over its enzymatic function such that stimulation of
NKA/Src signaling by endogenous ligands such as cardiotonic steroids (CTS) leads to
internalization of basolateral NKA ion-pump (1), stimulates phosphorylation-mediated
inactivation of apical NHE3 prior to internalization (2), and decreases membrane expression of
basolateral NBCe1A directly or secondary to NHE3 reduction (3)- leading to tonic inhibition of
RPT Na+ reabsorption (C). Based on the dual functions of NKA, a loss of NKA/Src receptor
function in the hypomorphic NKA 1 mouse would be expected to result in a dismantled
NKA/Src receptor complex leading to an increased membrane expression of RPT NHE3 and
NBCe1A, and thereby promoting reabsorption of Na+ and water (D). The hyper-reabsorptive
phenotype of the hypomorphic RPT1-/- mice indicate that actually NKA/Src receptor is
functionally dominant over the classic enzymatic NKA function in RPT Na+ reabsorption. CTS:
cardiotonic steroids; NKA: Na/K-ATPase; NBCe1A: NaHCO3 cotransporter 1A; NHE3: NaH
exchanger 3. Created with BioRender.com
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Materials and Methods
Reagents.
The polyclonal anti-Na/K-ATPase 1 antiserum NASE, polyclonal anti-Na/K-ATPase
2, and polyclonal anti-Na/K-ATPase 3 used for tissue western blots were raised in rabbits and
were generous gifts from Drs. T. Pressley and P. Artigas at Texas Tech University Health
Sciences Center (Pressley, 1992). The monoclonal anti-Na/K-ATPase 1 antibody (6F) was
obtained from the Developmental Studies Hybridoma Bank at the University of Iowa was used
for cellular western blot analysis. The monoclonal Anti-Na/K-ATPase 1 from Millipore (#05369) was used for immunocytochemistry. Anti-NHE3 (Millipore, catalogue #AB3085MI) and
anti-phosphorylated NHE3 at serine 552 (Santa Cruz Biotechnology, Catalogue #sc-516102)
were selected based on previous literature (Kurashima et al., 1997). Anti-NBCe1A chicken
antibody was developed by Dr. Michael Romero (Mayo Clinic) and gifted to us for use. Anti-αtubulin antibody (sigma, catalogue #T5168) and anti-E-cadherin (Cell Signaling, Catalogue #
3195S) were used as a loading control for total and membrane lysates, respectively. The c-Src
antibody and caveolin-1 antibody for western blot were both from Cell Signaling #2108S and
#3267, respectively). The polyclonal anti-Tyr(P)418-Src antibody from Invitrogen(#44-660G)
was used for immunocytochemistry. Secondary antibodies were horseradish peroxidaseconjugated anti-rabbit (R&D systems, Catalogue# HAF008), anti-chicken (Invitrogen,
Catalogue# SA1-72064) and anti-mouse (Santa-Cruz biotechnology Inc., Catalogue# sc516102).22Na+ was obtained from PerkinElmer (Catalogue # NEZ081100UC)
Cell Culture.
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The parental LLC-PK1 cells were purchased from ATCC. Mutant cell lines used in this
work were derived from LLC-PK1 cells. The generation of Na/K-ATPase α1 knockdown PY-17
cells from LLC-PK1 has been described in details (Liang et al., 2006). PY-17 cells express about
8% of α1 Na/K-ATPase in comparison to LLC-PK1 cells, and do not express other isoforms of
Na/K-ATPase.
Using the well-established protocol of knockdown and rescue, we have generated several
stable cell lines (Lai et al., 2013; Xie et al., 2015; Yan et al., 2013). The generation and
characterization of the α1-rescued AAC-19 cells, α1 mutant-rescued Y260A, α2-rescued LX-α2,
and α2 mutant-rescued cells LY-a2 used in this study have been reported (Banerjee et al., 2018;
Lai et al., 2013; J. X. Xie et al., 2015; Yu et al., 2018). After cells reached 95-100% confluence,
they were serum-starved overnight and used for experiments. All cell lines were cultured in
DMEM plus 10% FBS with 1% penicillin/streptomycin. All cells were grown in 100mms dishes
and serum-starved at 90-100% confluency for 24hrs before isolation of protein for biochemical
analysis, unless otherwise stated.
Transepithelial 22Na flux.
To measure active transepithelial 22Na+ flux, a transepithelial 22Na+ transport assay was
performed in LLC-PK1 and PY-17 monolayers (grown on Costar Transwell culture filter inserts,
filter pore size: 0.4 μm, Costar, Cambridge, MA) as previously described (H. Cai et al.,
2008). Briefly, transepithelial 22Na+ flux (apical to basolateral) was determined by counting
radioactivity in the basolateral aspect at 1 h after 22Na+ (1uCi/mL) addition on the apical part of
the transwell insert.
Measurement of Transepithelial electrical Resistance (TER).
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To measure paracellular permeability, TER was measured in confluent monolayers of
serum-starved LLC-PK1 and PY-17 (grown on Costar Transwell culture filter inserts, filter pore
size: 0.4 μm, Costar, Cambridge, MA). EVOM2 (Epithelial Volt Ohm Meter; World Precision
Instruments) along with STX-2 probe (World Precision instruments) were utilized for the TER
measurements. Final values were obtained by subtracting the resistance of the bathing solution
and an empty support, and then dividing the surface area of insert. Results are expressed as ohms
per square centimeter.
Immunocytochemistry.
Cells were cultured on glass coverslips until 80% confluency was achieved. After being
fixed with Methanol and washed with 1x PBS, the cells were permeabilized for 10 min with
0.1% Triton X-100 in PBS. The cells were washed again with 1xPBS and blocked with 5% horse
serum in PBS for 30mins. Primary antibodies for NKA α1 and p-Src were diluted to 1:100 in 2%
BSA in PBS and coverslips were incubated with antibodies overnight at 4°C. After three washes
with PBS, AlexaFluor 555/488–conjugated antibodies were added and incubated for 1hr at room
temperature. Samples were washed and mounted onto slides using VectorMount mounting
media. Cells were visualized using Leica confocal SP5 microscope equipped with a 63x/1.3 oil
objective. To avoid the cross-talk between the two fluorescent dyes, we used the sequential
method featured by the Leica confocal microscope to acquire the images for measuring
colocalization of the two proteins.
Animals.
Mice with floxed endogenous NKA α1 isoform developed by the Kansas University Medical
Center Core were crossed with Sglt2.iCre mice initially developed by Dr. Michel Tauc (Rubera
et al., 2004) and obtained through the European Mouse Mutant Archive (EMMA) repository
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(https://www.infrafrontier.eu/resources-and-services/access-emma-mouse-resources). Mice
homozygous for floxed α1 (α1flox/α1flox) and heterozygous for Sglt2iCre (Sglt2iCre/WT) were
bred with 1flox/1flox Sglt2WT/WT mice (Figure 6A), resulting in litters of 1flox/floxSglt2iCre/WT (RPT1-/-) mice with α1flox/α1flox Sglt2WT/WT controls (RPT1+/+) (H. C. Li
et al., 2013; Rubera et al., 2004). The mice generated were assessed for the presence of
heterozygous SGLT2-Cre and homozygous floxed Atp1a1 by PCR on genomic DNA extracted
from tail clips collected from bred mice (Figures 6B-C).
Mice with heterozygous floxed endogenous NHE3 were generously provided by Dr. M.
Soleimani at University of Cincinnati and were crossed with the previously generated
1flox/flox-Sglt2iCre/WT (RPT1-/-) mice resulting in litters of 1flox/flox-NHE3flox/floxSglt2iCre/WT (RPT1-/-NHE3-/-) mice with α1flox/α1flox-NHE3flox/flox-Sglt2WT/WT
controls (RPT1+/+NHE3+/+). The mice generated were assessed for the presence of
heterozygous SGLT2-Cre, homozygous floxed Atp1a1, and homozygous floxed Nhe3 by PCR
on genomic DNA extracted from tail clips collected from bred mice (Figures 12B-D).
RPT1-/-, RPT1-/-NHE3-/- and their control littermates were housed in 12-hour light and
dark cycles at constant temperature and humidity. All animal procedures were approved by the
Marshall University Institutional Animal Care and Use Committee.
Metabolic Cage analysis.
Mice were housed individually in metabolic cages (manufactured by TechniPlast) for two
consecutive days including 24hrs for acclimatization and the following 24hrs for measuring food
and water intake, and urine output. Feces collected over 24hrs were weighed, dried over 72hrs,
and weighed again to calculate the loss on drying to measure fecal water excretion.
Urine and Serum analysis.
65

Urine collected over 24hrs using metabolic cages was sent to Idexx Laboratories, Inc. for
analysis of sodium, potassium, calcium, magnesium, phosphorus, creatinine, pH and glucose.
Serum isolated from collected blood was sent to Idexx for analysis of sodium, potassium,
calcium, magnesium, phosphorus, creatinine, and BUN. Aldosterone concentration was
measuring in serum using Aldosterone Elisa kit (Cayman chemicals, Catalogue #501090) as per
the manufacturer’s instructions. Atrial natriuretic peptide concentration was measured in serum
using Atrial Natriuretic Peptide EIA kit (Sigma, Catalogue#RAB0385). For Hematocrit
measurement, tail vein was clipped and whole blood samples were collected by using a
Heparinized Microhematocrit Capillary Tube (Produce number: 22-362-566, Fisherbrand,
Pittsburgh, PA, USA) and then centrifuged for 5 min in a Unico Micro-Hematocrit Centrifuge
(Model: C-MH30, Dayton, NJ, USA).
Measurement of Exhaled Breath Condensate (EBC).
We measured the water in the expired air as described (Wilhelm, Frydrychova, & Vizek,
1999). Conscious mice were individually placed in a body box [volume of 3L] for one hour with
positive air in-flow at the rate of 500mL/min. The outlet of the box was connected to a stoppered
glass flask that was submerged in dry ice to condense water in the expired air. The weight of the
exhaled breath condensate was measured to assess the amount of water in exhaled air over 1
hour.
Transcutaneous FITC-sinistrin decay to measure glomerular filtration rate (GFR)
in conscious mice.
The procedure was performed as previously described (Scarfe et al., 2018). In short, the
transcutaneous device (MediBeacon GmbH, Germany) was fixed to the depilated skin on the
back of adult mice using a double-sided adhesive patch (Lohmann, Neuwied, Germany).
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Transcutaneous measurement started with background reading for 5 min. before 7.5mg/100g BW
FITC-Sinistrin (Fresenius Kabi, Linz, Austria; diluted in 0.9% saline; Braun, Melsungen,
Germany) was administered I.V. via retro-orbital route. Animals were allowed to fully recover
and move freely until transcutaneous measurement was stopped after 90 minutes. Using a 1compartment model, the half-life of FITC-Sinistrin was calculated from the transcutaneous
measured kinetic by the MediBeacon software.
Urine and Serum Li+ Clearance tests.
To characterize proximal tubular function, we injected mice subcutaneously with 10
mmol/kg of LiCl (Huls et al., 2007; Wood, Goodwin, De Souza, & Green, 1986). After
collecting blood from all mice before injection, blood was collected at selected time-points of
peak 1hr, half-life 3hrs, and 6hrs after injection (Huls et al., 2007). To reduce influence of
variations in injection volume, all values were normalized to peak 1hr serum [Li+] concentration.
For urine clearance test, mice were acclimatized in metabolic cage for 24hrs before injecting
mice subcutaneously with 10mmol/kg of lithium chloride and placing them back in the
individual metabolic cages. Urine was collected over 24hrs and blood was collected at 24hrs
after injection. Serum was isolated from all collected blood and stored in -20 °C. [Li+]
concentrations were determined in serum and urine by using Contra-300 model of atomic
absorption spectrophotometer (Analytik Jena, Upland, CA).
Tissue Collection.
Mice were anaesthetized with 50mg/kg pentobarbital administered vid intra-peritoneal
(I.P.) injection. Tissues were dissected and weighed. Kidneys used for western blot analysis were
flash frozen in liquid nitrogen then stored at -80 until later use. Kidneys used for histological
analysis were fixed in 10% neutrally buffered formalin for 24 hours then stored in 70% ethanol
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until they were embedded in paraffin blocks. The outer darker cortical region rich in glomerular
and proximal and distal tubules was identified and demarcated from the lighter inner medullary
region for all histological assessments.
Immunohistochemistry.
Kidneys were collected and then washed twice with ice-cold PBS, fixed with 10%
neutrally buffered formalin for 24 hours, then stored in 70% ethanol until they were embedded in
paraffin blocks. Cross-section of the mid-region of the kidney were immunostained for Periodic
acid schiff by Wax-it Histology Services Inc. (Vancouver, Canada) to analyze structural and
morphometric changes in kidney. Additional sections were stained for NKA 1 and Villin-1, and
NKA 1 and phosphoY418-Src by Wax-it, Inc. The samples were examined on a Leica confocal
SP5 microscope under 100x oil-immersion lens. The images were processed with the Leica
Application Suite advanced fluorescence (LAS/AF) suite (Leica microsystems, Wetzlar,
Germany) and FIJI ImageJ for quantification and to construct figures. Proximal tubules were
selected as regions of interest (ROI) based on staining of proximal tubule marker villin-1 (stained
purple). They were then manually, randomly and blindly annotated and the integrated density of
NKA 1 fluorescent staining and adjacent background per ROI was measured by the ImageJ
software (from National Institute of Health). Measurements obtained were corrected for
background per ROI and normalized to average of control values. Colocalization was determined
by examination of merged images. For the colocalization described, the 488 nm Argon and 561
nm diode lasers were used, as well as the 633nm He-Ne laser, to see the expression of
phosphoTyr418Src, NKA, and Villin-1 respectively. Colocalization of phosphoTyr418Src and NKA
was quantified using coloc2 plugin in FIJI ImageJ.
Morphometric tissue analysis.
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Images of kidney sections stained with periodic acid schiff were processed by Wax-it,
Inc. and images were captured with digital whole slide scanning. Aperio ImageScope software
was used to determine the cross-sectional area of each glomerulus and proximal tubule (F. Chow,
Ozols, Nikolic-Paterson, Atkins, & Tesch, 2004; Gotoh et al., 2010; Kotelevtsev et al., 1999).
Every glomerulus was counted to determine the average number of glomerulus per section (n=3
sections/sample). In each section, 200 proximal tubules were randomly and blindly selected in
the cortical region and manually analyzed for cross-sectional area and number of cells per tubule,
(n=3 sections/sample).
Purification of Caveolin-rich Membrane Fractions.
Caveolin-rich membrane fractions were obtained via sucrose gradient fractionation as
described previously (Yiliang Chen et al., 2009). Briefly, cells were washed with ice-cold
phosphate-buffered saline and cells were scraped and ground tissue was suspended in 2 ml of
500 mM sodium carbonate, pH 11.0. The cell lysates were homogenized by a Potter-Elvehjen
homogenizer (three 6-s bursts) and subjected to sonication using Branson digital sonifier (three
40-s bursts). The homogenates were then adjusted to 45% sucrose by addition of 2 ml of 90%
sucrose in MBS (25 mM MES, 0.15 M NaCl, pH 6.5) and placed at the bottom of ultracentrifuge
tubes. The ultracentrifuge tubes were then loaded with 4 ml of 35% sucrose and 4 ml of 5%
sucrose (both in MBS containing 250 mM sodium carbonate) and centrifuged at 39,000 rpm for
17 h in an SW40 rotor (Beckman Instruments). Twelve gradient fractions of 1 ml were collected
from the top to the bottom. Among the fractions, fraction 4 and 5 were combined and diluted
with 4 ml of MBS containing 250mM sodium carbonate, then centrifuged at 40,000 rpm in a
Beckman type 70 rotor for 1 h. The pellet was resuspended in 250 µL of MBS and is considered
as caveolin-enriched caveolar fraction.
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Western Blot.
Kidney cortex was separated from medulla on ice, as described (Veiras et al., 2017).
Cortex was ground into fine powder with a mortar and pestle and homogenized in ice-cold
radioimmunoprecipitation (RIPA) buffer (0.25% sodium deoxycholate, 1% NP-40, 1mM EDTA,
1mM PMSF, 1mM sodium orthovanadate, 1mM Sodium fluoride, 150mM NaCl, 50mM TrisHCl, pH 7.4 and 1% protease inhibitor cocktail) with a Potter-Elvehjen homogenizer.
Homogenates were rotated for 15mins and centrifuged at 14,000xg for 15min, supernatants were
collected, and protein content was measured using DC protein assay kit from BioRad (catalogue
number 500-0114 and 500-0113). For membrane protein analysis, kidney cortex was
homogenized consistently with Mem-PER kit extraction reagents containing protease inhibitor
cocktail (Fisher Catalogue #PI89842) as per manufacturer’s instructions. Isolated membrane
protein was assessed for concentration using DC protein assay kit from BioRad (catalogue
number 500-0114 and 500-0113). Sucrose-gradient fractions were loaded by equal volume. For
the rest, equal amounts of protein of each sample were loaded, separated by SDS-PAGE, and
transferred to nitrocellulose membranes.
Membranes probed for NKA α1, phosphorylated ser552-NHE3, NHE3, NBCe1A, c-Src,
caveolin-1 were blocked in 5% milk in TBST, then primary antibodies diluted in blocking buffer
were added overnight at 4degree Celsius. Nitrocellulose and PVDF membranes were visualized
with SuperSignal West Pico Chemiluminescent Substrate (Fisher Cat# PI34080) or in case of
weak signal with Enhanced Luminal Reagent (Perkin Elmer Cat# NEL103001EA) using
radiographic film. Densitometry quantifications was performed using ImageJ software.
Glucose Tolerance Test.
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Fasting blood glucose was measured from the tail vein using a OneTouch Ultra
glucometer after a 6 hour fast. A 20% glucose solution was administered via intraperitoneal
injection at a dose of 2 g/kg BW. Blood glucose was measured from the tail vein at 15, 30, 45,
60, 90, and 120 min. post injection. The area under the curve was calculated to determine
glucose tolerance.
Insulin Tolerance Test.
Fasting blood glucose was measured from the tail vein using a OneTouch Ultra
glucometer after a 6 hour fast. Insulin (0.15 units/mL) was administered via intraperitoneal
injection at a dose of 0.75 units/kg BW. Blood glucose was measured from the tail vein at 15, 30,
45, 60, 90, and 120 min. post injection. The area under the curve was calculated to determine
insulin resistance.

Statistical Analysis.
Statistical analysis was performed using GraphPad Prism (GraphPad Sofware, San Diego,
California USA). All data presented are mean ± S.E.M, and statistical analysis was performed
using the Student’s t test. When more than two groups were compared, one-way ANOVA was
performed prior to post-hoc comparison of individual groups using Tukey’s multiple comparison
test. Significance was accepted at p<0.05.
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CHAPTER 3
RENAL PROXIMAL TUBULE-SPECIFIC ALTERATION OF THE NKA/SRC
RECEPTOR COMPLEX IN THE MOUSE: EVIDENCE FOR SEXUAL DIMORPHISM
Introduction
The regulation of Na+ transport in the renal proximal tubule (RPT) is vital to systemic
Na+ balance and blood volume homeostasis. As two-third of Na+ absorbed in the RPT,
modulation of the transport in this region also has pathological implications.
Na+ /K+-ATPase (NKA) expressed on the basolateral membrane of RPT cells serves dual
counteractive functions- the anti-natriuretic enzymatic ion-pump generating the Na+ gradient for
absorption of Na+ by apical transporters like NHE3, and the natriuretic regulatory receptor
complex that when activated results in interdependent inhibition of NKA, NHE3 and Na+/HCO3cotransporter-1A(NBCe1A), and transepithelial Na+ flux (Figure 5, Figure 11). The RPT-specific
NKA α1 hypomorphic mice (RPTα1-/-) exhibit increase in RPT-mediated Na+ reabsorption in
both male and female mice (Figures 9-10). Notably, the natriuretic non-enzymatic function of
NKA shows functional dominance over the anti-natriuretic NKA enzymatic function as
evidenced by studies in the RPT-specific hypomorphic NKA 1 mouse (RPT1-/-, Figure 11).
The restoration of urine and Na+ output in the RPT-specific NKA 1 and NHE3 double
hypomorphic mice (RPT1-/-NHE3-/-) confirmed the importance of NHE3 in the NKA 1mediated regulation of Na+ absorption by RPT (Figure 11). However, the specific molecular
mechanisms involved in the potent NKA receptor-mediated tonic inhibitory function , which has
been linked to the NKA/Src functions in vitro, has not been tested in vivo.
NKA binds and interacts with Src kinase to form a receptor signaling complex. GST pull
down assays that demonstrate NKA interacts with Src via two domain- domain interactions (Z.
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Li et al., 2009; Tian et al., 2006). The second cytosolic domain (CD2) acts as a ligand to Src SH2
domain and is necessary for activation and targeting of Src (Banerjee et al., 2015; Tian et al.,
2006). Specifically, the Y260 residue in CD2 of NKA α1 is the Src phosphorylation and binding
site (Banerjee et al., 2015). Binding at this site is constitutive and independent of NKA
conformation and thereby ouabain has no effect on this specific interaction (Banerjee et al.,
2015; Tian et al., 2006). The binding to CD2 domain may function as a hinge to keep the
activated Src bound to the signaling NKA for specific and robust signal transmission (Banerjee
et al., 2015; Tian et al., 2006). Phosphorylation of the Y260 residue of NKA α1 (pY260) by Src
is also necessary for the binding of Src and the associated signaling transduction (Banerjee et al.,
2018). Renal epithelial cells with knockdown of endogenous NKA α1 and rescue of expression
with Y260A mutant NKA α1 exhibit a significant decrease in Src-binding and show a loss of
ouabain-mediated activation of signaling molecules downstream to Src, like ERK and AKT
(Banerjee et al., 2018). EGF and ouabain treatment of LLC-PK1 cells resulted in increased
pY260 in time and dose-dependent manner (Banerjee et al., 2018). Thus, pY260 represents a
feature of Src regulation relevant to NKA receptor function. On the other hand, Src kinase
domain binds to nucleotide binding domain of the cytoplasmic NKA α1 (CD3) in its E1
conformation (Z. Li et al., 2009; Tian et al., 2006; J. X. Xie et al., 2015). Binding of ouabain to
NKA α1 stabilizes the conformation of NKA α1 in E2, which results in the freeing of the Src
kinase domain from CD3 and subsequently the disinhibition of Src to activate downstream
signaling molecules (Z. Li et al., 2009; Tian et al., 2006). The identification of the 20 amino acid
sequence in the N domain that binds Src kinase resulted in development of the cell-permeable
peptide pNaktide that inhibits Src-kinase both in vitro and in vivo (Z. Li et al., 2009; Z. Li et al.,
2011; Liu et al., 2016b; Sodhi et al., 2015; Sodhi et al., 2017).
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Previous pharmacological studies have proposed Src-mediated signaling in the NKA nonenzymatic inhibition of RPT NHE3 and Na+ transport (H. Cai et al., 2008; Godinho et al., 2017).
Notably, like RPT1-/-, renal epithelial cells expressing Src-binding mutant Y260A NKA 1
show a 50% decrease in phosphorylation-mediated inactivation of NHE3 compared to the wildtype NKA 1 expressing AAC-19 cells (Figure 14), implicating NKA/Src in the regulation of
NHE3. While, RPT1-/- display a renal cortical redistribution of c-Src from the caveolar to noncaveolar fractions in absence of NKA 1 (Figure 13), the specific physiological importance of
NKA/Src receptor-mediated regulation in NHE3 in RPT Na+ transport is yet to be elucidated.
Based on previous reports (H. Cai et al., 2008; Godinho et al., 2017) and our in vitro
studies in the genetically modified cells (Figure 14), we hypothesized that a loss of NKA/Src
interaction and binding in RPT will lead to a loss of tonic inhibition of Na+ transport and
decrease natriuresis in both male and female mice as it did in the RPT1-/-. To test the proposed
NKA/Src mechanism, we utilized a genetic approach to suppress the endogenous Atp1a1, the
gene that encodes NKA 1, and rescue the expression of NKA 1 with exogenous wild-type or
Y260A Src-signaling null mutant NKA 1 in RPT-specific mouse model. Our investigation
suggests a sexual dimorphism in the NKA/Src mechanism.
Materials and Methods
Reagents.
The polyclonal anti-Na/K-ATPase 1 antiserum NASE, used for tissue western blots
were raised in rabbits and were generous gifts from Drs. T. Pressley and P. Artigas at Texas Tech
University Health Sciences Center (Pressley, 1992). Anti-phospho-Y260- Na/K-ATPase α1Assay Biotech (Fremont, CA) was used as described (Banerjee et al., 2018). Anti-NHE3
(Millipore, catalogue #AB3085MI) and anti-phosphorylated NHE3 at serine 552 (Santa Cruz
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Biotechnology, Catalogue #sc-516102) were selected based on previous literature (Kurashima et
al., 1997). Anti-α-tubulin antibody (sigma, catalogue #T5168) and anti-E-cadherin (Cell
Signaling, Catalogue # 3195S) were used as a loading control for total and membrane lysates,
respectively. Secondary antibodies were horseradish peroxidase-conjugated anti-rabbit (R&D
systems, Catalogue# HAF008) and anti-mouse (Santa-Cruz biotechnology Inc., Catalogue# sc516102).
Animals.
Mice with floxed Neo-STOP cassette upstream of wild type (WT) NKA 1 or Y260A
mutant NKA 1 construct targeted at the Rosa26 locus on chromosome 6 were generated and
obtained through a contract with inGenious Targeting Laboratory, Inc. (Stony Brook, NY) and
bred with previously generated RPT1-/- mice with homozygous floxed endogenous NKA α1
isoform, homozygous Rosa26-WT or Rosa26-Y260A mutant Atp1a1, and heterozygous for
Sglt2.iCre mice. The mice generated were assessed for the presence of the SGLT2-Cre
transgene, homozygous floxed Atp1a1, and homozygous Rosa26-WT or Rosa26-Y260A NKA
α1 by PCR on genomic DNA extracted from mouse tail clips.
All animals were housed in 12-hour light and dark cycles at constant temperature and
humidity. All animal procedures were approved by the Marshall University Institutional Animal
Care and Use Committee.
Metabolic Cage analysis.
Mice were housed individually in metabolic cages (manufactured by TechniPlast) for two
consecutive days, including 24 hours for acclimatization and the following 24 hours for
measuring food and water intake, and urine output.
Urine and Serum analysis.
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Urine collected over 24 hours using metabolic cages was sent to Idexx (North Grafton,
MA, USA) for analysis of sodium, potassium, calcium, magnesium, phosphorus, creatinine, pH
and glucose. Serum isolated from blood collected from mesenteric artery of the four month mice
was sent to Idexx for analysis of sodium, potassium, calcium, magnesium, phosphorus,
creatinine, and blood urea nitrogen (BUN).
Serum Lithium Clearance tests.
To characterize RPT function, we injected mice subcutaneously with 10 mmol/kg of
lithium chloride(Huls et al., 2007; Koomans, Boer, & Mees, 1989; Wood et al., 1986). After
collecting blood from all mice before injection, blood was collected at selected time-points of
peak one hour, half-life three hours, and six hours after injection. To reduce the influence of
variations in injection volume, all values were normalized to peak 1hr serum lithium
concentration. Serum was isolated from all collected blood and stored in -20 °C. Lithium
concentrations were determined in serum by using Contra-300 model of atomic absorption
spectrophotometer (Analytik Jena, Upland, CA).
Tissue Collection.
Mice were anaesthetized with 50mg/kg pentobarbital administered via intra-peritoneal
(I.P.) injection. Tissues were dissected and weighed. Kidneys used for western blot analysis were
flash frozen in liquid nitrogen then stored at -80 until later use. Kidneys used for histological
analysis were fixed in 10% neutrally buffered formalin for 24 hours then stored in 70% ethanol
until they were embedded in paraffin blocks. The outer darker cortical region rich in glomerular
and proximal and distal tubules was identified and demarcated from the lighter inner medullary
region for all histological assessments.
Immunohistochemistry.
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Kidneys were collected and then washed twice with ice-cold PBS, fixed with 10%
neutrally buffered formalin for 24 hours, then stored in 70% ethanol until they were embedded in
paraffin blocks. Cross-section of the mid-region of the kidney were immunostained for Periodic
acid schiff by Wax-it, Inc (Vancouver, Canada) to analyze structural and morphometric changes
in kidney. Additional sections were stained for NKA 1 and Villin-1, by Wax-it, Inc. The
samples were examined on a Leica confocal SP5 microscope under 100x oil-immersion lens. The
images were processed with the Leica Application Suite advanced fluorescence (LAS/AF) suite
(Leica microsystems, Wetzlar, Germany)
Morphometric tissue analysis.
Images of kidney sections stained with periodic acid schiff (PAS) were processed by
Wax-it, Inc. and images were captured with digital whole slide scanning. Aperio ImageScope
software was used to determine the cross-sectional area of each glomerulus and proximal tubule
(F. Chow et al., 2004; Gotoh et al., 2010; Kotelevtsev et al., 1999). Every glomerulus was
counted to determine the average number of glomerulus per section (n=3 sections/sample). In
each section, 200 proximal tubules were randomly and blindly selected in the cortical region and
manually analyzed for cross-sectional area and number of cells per tubule, (n=3
sections/sample).
Cortical Membrane preparations and Western Blotting.
Kidney cortex was separated from medulla on ice, as described (Veiras et al., 2017; Yang
et al., 2018). To isolate membrane protein, the kidney cortex was homogenized with Mem-PER
kit extraction reagents containing protease inhibitor cocktail (Fisher Catalogue #PI89842) as per
manufacturer’s instructions. Isolated membrane protein was assessed for concentration using the
DC protein assay kit from BioRad (catalogue number 500-0114 and 500-0113). Equal amounts
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of protein of each sample were loaded, separated by SDS-PAGE, and transferred to
nitrocellulose membranes.
Membranes probed for pY260 NKA α1, total NKA α1, NHE3, and loading control ECadherin were blocked in 3% or 5% milk in TBST, then primary antibodies diluted in blocking
buffer were added overnight at four degrees Celsius. Nitrocellulose membranes were visualized
with SuperSignal West Pico Chemiluminescent Substrate (Fisher Cat# PI34080) or in case of
weak signal with Enhanced Luminal Reagent (Perkin Elmer Cat# NEL103001EA) using
radiographic film. Densitometry quantifications was performed using ImageJ software.
Statistical Analysis.
Statistical analysis was performed using GraphPad Prism (GraphPad Sofware, San Diego,
California USA). All data presented are mean ± S.E.M, and statistical analysis was performed
using the Student’s t test. When more than two groups were compared, one-way ANOVA was
performed prior to post-hoc comparison of individual groups using Tukey’s multiple comparison
test. Significance was accepted at p<0.05.
Results
Generation of mouse with RPT-specific expression of WT NKA 1 in RPT1-/We generated transgenic mice containing a floxed Neo-STOP cassette upstream of wild
type (WT) NKA 1 construct targeted at the Rosa26 locus on chromosome 6 and floxed
endogenous ATP1a1 on chromosome 3. As illustrated in Figure 16, upon crossing with SGLT2Cre mice, RPT-specific expression of Cre Recombinase removes the exons 15-18 of ATP1a1
causing frameshift leading to nonsense mRNA-mediated decay and the Neo-STOP cassette,
which allows knockout of endogenous NKA 1 and the expression of the exogenous WT NKA
1 in the RPT (RPT1WT).
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Homozygous RPT1WT were viable. Body weight, food consumption, and water intake,
were not modified in male and female RPT1WT (Tables 8 & 9). Renal cortices stained with
villin-1, a microvillar actin bundling protein specifically expressed in the RPT (magenta) and
NKA 1 (red) were obtained from four month old male and female RPT1WT and their controls
(RPT1control) (Figures 17A-B). Western Blot showed a visible rescue in the expression of total
NKA 1 expression in renal cortex of RPT1WT relative to RPT1control in both male and female
mice, in contrast to the decrease observed in the cortex of male and female RPT1-/- mice
compared to their controls (RPT1+/+) (Figures 17 C-D), also assessed in Figure 7. Thus, the
visibly comparable expression of total NKA 1 in RPT1WT suggests a successful rescue of
NKA 1 expression in the RPT of these mice.
Generation of mouse with RPT-specific expression of Src-binding mutant Y260A
NKA 1 in RPT1-/Expression of Y260A mutant NKA 1 in pig renal epithelial cells results in loss of Srcbinding to NKA and the associated non-enzymatic signal transduction, but not the enzymatic
ion-pumping function in vitro (Banerjee et al., 2018). Using the strategy depicted in Figure 17
for rescue of WT Atp1a1, we generated mice with RPT-specific expression of exogenous Y260A
NKA 1 Src-binding mutant (RPT1Y260A).
Homozygous RPT1Y260A were viable. Body weight, food consumption, and water
intake, were not modified in male and female RPT1Y260A (Table 10 &11). The rescue of NKA
α1 was confirmed by immunostaining of renal cortices obtained from four month old male and
female RPT1Y260A and their respective controls (RPT1control) with villin-1, marker for RPT
(magenta), and NKA 1 (red) (Figures 18A-B). Western blot analysis indicated a decrease of
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about 50% of cortical pY260 NKA 1 with no change in total NKA 1 in both male and female
RPT1Y260A mice compared to their controls, confirming rescue of NKA 1 expression with the
mutant Y260A NKA 1 in membranes in the RPT (Figures 18C-H).

Figure 16: Strategy for RPT-specific Wild-type and Y260A signaling mutant Atp1a1 rescue
in mouse.
Strategy for Cre-inducible knockout on Chromosome 3 of floxed Exons 15-18 of endogenous
gene for NKA α1(Atp1a1) and rescue with exogenous WT or mutant (Y260A) NKA α1 on
chromosome 6 at Rosa26 locus. Expression of Cre Recombinase is driven by the SGLT2
promoter which is tissue specific to RPT S1/S2 segments in the kidney.
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Figure 17: Generation of RPT-specific Wild-type Atp1a1 rescue mouse model.
(A-B) Immunofluorescence for NKA α1 (red) and RPT brush-border marker villin-1(magenta) of
kidney cross-sections from RPTα1WT and RPTα1control male and female mice. Scale bars: 25 µm.
(C-D) Representative western blots for total NKA α1 along with loading control -Tubulin for
male and female RPT1-/-, RPT1WT, and their respective control mice (n=3-5).

RPTα1control

RPTα1WT

Body Weight (g)

34±2.0

30±0.8

Water intake (g)

6.7±0.7

7.6±0.3

Food intake (g)

6.3±0.5

6.4±0.4

Table 8: Basal metabolic characteristics of male RPTα1WT mice.
Values are mean±SEM for four month male and mice (n=5/genotype). No significant difference
was observed between RPTα1WT and their respective sex-matched controls by Student’s t-test.
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control

RPTα1

RPTα1

WT

Body Weight (g)

25±1.4

25±0.7

Water intake (g)

8.6±1.0

7.6±0.6

Food intake (g)

7.1±0.5

6.1±0.5

Table 9: Basal metabolic characteristics of female RPTα1WT mice.
Values are mean±SEM for four month female mice (n=7/genotype). No significant difference
was observed between RPTα1WT and their respective controls by Student’s t-test.
control

RPTα1

RPT α1

Y260A

Body Weight (g)

30±2.0

32±1.0

Water intake (g)

6.6±0.3

7.0±0.4

Food intake (g)

6.1±0.6

5.5±0.4

Table 10: Basal metabolic characteristics of male RPTα1Y260A mice.
Values are mean±SEM for four month male mice (n=6-7/genotype). No significant difference
was observed between RPTα1Y260A and their respective controls by Student’s t-test.
control

RPTα1

RPTα1

Y260A

Body Weight (g)

25±1.0

25±0.6

Water intake (g)

7.9±0.5

8.1±0.4

Food intake (g)

5.2±0.3

6.0±0.4

Table 11: Basal metabolic characteristics of female RPTα1Y260A mice.
Values are mean±SEM for four month female mice (n=6-7/genotype). No significant difference
was observed between RPTα1Y260A and their respective controls by Student’s t-test.
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Figure 18: Generation of RPT-specific Y260A signaling mutant NKA α1 rescue mouse
model.
(A-B) Immunofluorescence for NKA α1 (red) and RPT brush-border marker villin-1(magenta) of
kidney cross-sections from male and female RPTα1Y260A and RPTα1control mice. Scale bars: 25
µm. Representative western blots and quantification of pY260 and total NKA α1 in renal cortex
homogenates from male (C-E) and female (F-H) RPTα1Y260A, RPTα1WT and RPTα1control control
mice. All quantifications were normalized to α-tubulin followed by normalization to the average
of control values in each gel. Values are mean ± SEM of n=3-4 and data were analyzed by
Student’s t-test.
RPT expression of mutant Y260A NKA 1 reveals sexual dimorphism in NKA/Src
regulation of Na+ absorption
To test whether the Src-binding mutant rescue RPT1Y260A mice have a hyperreabsorptive renal phenotype compared to WT NKA 1 rescue RPT1WT mice, as expected
based on our observations in AAC-19 and Y260A cells (Figure 14), male and female mice with
RPT-specific WT NKA 1 rescue, mutant Y260A NKA 1 rescues, and their respective controls
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were functionally evaluated. The mice were acclimated for 24 hours in metabolic cages followed
by 24 hours urine collection to assess daily urine and Na+ output, and urine chemistry. In both
male and female RPT1WT mice, expression of exogenous WT NKA 1 in RPT1-/- resulted in
the restoration of daily urine and absolute Na+ output to values comparable to controls (Figures
19A-D).
However, in mice expressing Src-signaling null Y260A mutant NKA 1, we observed a
striking sexual dimorphism in the urinary phenotype. While female RPT1Y260A exhibited a
robust and significant 60% decrease in urine and 40% decrease in absolute Na+ output, male
RPT1Y260A showed insignificant change in their daily urine and Na+ output compared to
RPT1control mice (Figures 19E-H).

Figure 19: Rescue with Src-binding Y260A NKA α1 mutant decreases natriuresis and
diuresis in sex-dependent manner.
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Four month old mice were used to assess daily urine output and absolute Na+ excretion (UNa+V)
expressed as UNa+V = Urine [Na+] (mmol/mL) x Urine volume (mL/24h) in RPTα1WT male (AB) and female (C-D) mice, and RPTα1Y260A male (E-F) and female (G-H) mice. Results are
presented as mean ± SEM for n=5-11. Data were analyzed by t-test. *p<0.05, ***p<0.001 vs
RPTα1control.
Despite the significant decrease in natriuresis in females, urinary and serum
concentrations for most electrolytes, including Na+, K+, Cl-, and Ca2+, were within the normal
range (Tables 12-19). The reduced urine and Na+ output in females is consistent with the
proposed prevalent role of NKA/Src receptor function in the tonic inhibition of RPT Na+
reabsorption in vitro and in vivo, but the absence of hyper-reabsorptive phenotype in male
RPT1Y260A reveals a sexual dimorphism in the dependence on NKA/Src mediated inhibitory
mechanism.
RPTα1control

RPTα1WT

Sodium (mEq/L)

204±18

190±13

Potassium (mEq/L)

448±29

460±21

Chloride (mEq/L)

291±17

297±16

Creatinine (mg/dL)

46.0±4.2

41.8±3.6

Phosphorus (mg/dL)

126.0±20.0

90.8±7.4

Calcium (mg/dL)

8.34±1.5

8.44±1.5

Magnesium (mg/dL)

64.0±9.8

45.3±7.0

Table 12: Urine chemistry panel of male RPTα1WT and their controls (RPTα1control).
Values are mean ± SEM in four month male mice. No significant difference was observed
between RPTα1WT and their controls by Student’s t-test.
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RPTα1control

RPTα1WT

Sodium (mEq/L)

163±20

178±21

Potassium (mEq/L)

496±110

421±53

Chloride (mEq/L)

290±73

267±31

Creatinine (mg/dL)

42.8±8.4

40.7±4.5

Phosphorus (mg/dL)

100.0±14.0

75.7±7.2

Calcium (mg/dL)

10.2±1.40

7.8±0.54

Magnesium (mg/dL)

61.0±15

80.8±24

Table 13: Urine chemistry panel of female RPTα1WT and their controls (RPTα1control).
Values are mean ± SEM in four month female mice. No significant difference was observed
between RPTα1WT and their respective controls by Student’s t-test.

RPTα1control

RPTα1Y260A

Sodium (mEq/L)

159±8.8

163±14.0

Potassium (mEq/L)

371±24

384±36

Chloride (mEq/L)

244±17

245±19

Creatinine (mg/dL)

39.4±2.6

37.6±2.8

Phosphorus (mg/dL)

112±19.0

106±7.3

Calcium (mg/dL)

8.01±0.54

7.92±0.99

Magnesium (mg/dL)

53.1±4.3

49.6±4.6

Table 14: Urine chemistry panel of male RPTα1Y260A mice and their controls (RPTα1control).
Values are mean ± SEM in four month male mice. No significant difference was observed
between RPTα1Y260A and their controls by Student’s t-test.
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RPTα1control

RPTα1Y260A

Sodium (mEq/L)

170±14.0

195±8.1

Potassium (mEq/L)

395±42

518±45

Chloride (mEq/L)

252±25

313±17

Creatinine (mg/dL)

41.3±4.2

49.7±5.1

Phosphorus (mg/dL)

118±10

166±31

Calcium (mg/dL)

9.24±1.1

11.60 ±1.3

Magnesium (mg/dL)

60.8±3.6

79.2±19.0

Table 15: Urine chemistry panel of female RPTα1Y260A mice and their controls
(RPTα1control).
Values are mean ± SEM in four month female mice. No significant difference was observed
between RPTα1Y260A and their controls by Student’s t-test.

RPTα1control

RPTα1WT

Sodium (mEq/L)

153±3

152±3

Potassium (mEq/L)

4.9

6.2±0.2

Chloride (mEq/L)

112±0.6

112±2

Creatinine (mg/dL)

0.1

0.12±0.02

Phosphorus (mg/dL)

6.2±0.07

7.8±0.8

Calcium (mg/dL)

9.1±0.3

8.5±0.7

Albumin (g/dL)

2.7±0.07

2.7±0.03

BUN (mg/dL)

26±2

28±2

Total protein (g/dL)

4.5±0.1

4.6±0.1

Table 16: Serum chemistry panel of male RPTα1WT and their controls (RPTα1control).
Values are mean ± SEM in four month male mice. No significant difference was observed
between RPTα1WT and their controls by Student’s t-test.
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RPTα1control

RPTα1WT

Sodium (mEq/L)

157±3

154±4

Potassium (mEq/L)

5.5±0.3

5.5±0.7

Chloride (mEq/L)

112±5

112±1

Creatinine (mg/dL)

0.1±0.06

0.13±0.03

Phosphorus (mg/dL)

7.9±2

7.5±0.6

Calcium (mg/dL)

9.8±0.4

9.3±0.2

Albumin (g/dL)

2.8±0.05

2.9±0.06

BUN (mg/dL)

25±1

29±3

Total protein (g/dL)

4.6±0.2

4.8±0.2

Table 17: Serum chemistry panel of female RPTα1WT and their controls (RPTα1control).
Values are mean ± SEM in four month female mice. No significant difference was observed
between RPTα1WT and their controls by Student’s t-test.

RPTα1control

RPTα1Y260A

Sodium (mEq/L)

152±3

155±2

Potassium (mEq/L)

8.2±2.0

5.6±0.3

Chloride (mEq/L)

111±1

108±2

Creatinine (mg/dL)

0.13±0.03

0.13±0.03

Phosphorus (mg/dL)

8.1±0.9

8.3±0.8

Calcium (mg/dL)

9.1±0.2

9.6±0.0

Albumin (g/dL)

2.7±0.09

2.6±0.03

BUN (mg/dL)

22±0.7

32±2.0*

Total protein (g/dL)

4.6±0.20

4.5±0.09

Table 18: Serum chemistry panel of male RPTα1Y260A mice and their controls
(RPTα1control).
Values are mean ± SEM in four month male mice. Data analyzed by Student’s t-test. *p<0.05 vs
RPTα1control.
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RPTα1control

RPTα1Y260A

Sodium (mEq/L)

150±2

150±3

Potassium (mEq/L)

5.5±0.9

4.1±0.4

Chloride (mEq/L)

110±0.9

111±1.0

Creatinine (mg/dL)

0.13±0.03

0.17±0.03

Phosphorus (mg/dL)

7.8±0.4

7±1.0

Calcium (mg/dL)

9.3±0.06

8.7±0.20*

Albumin (g/dL)

2.8±0.03

2.7±0.06

BUN (mg/dL)

28±1

26±3

Total protein (g/dL)

4.6±0.07

4.5±0.20

Table 19: Serum chemistry panel of female RPTα1Y260A mice and their controls
(RPTα1control).
Values are mean ± SEM in four month female mice. Data analyzed by Student’s t-test. *p<0.05
vs RPTα1control.
Increased RPT Na+ absorption in female RPTα1Y260A mice
The reduction of natriuresis in female RPT1Y260A is consistent with the recently
identified functionally dominant NKA non-enzymatic signaling function in RPT Na+ transport.
Consequently, we set out to functionally confirm the role of RPT Na+ transport in the observed
hyper-reabsorption in these mice. Histological analysis after periodic acid schiff (PAS) staining
did not reveal any gross structural alteration in the kidneys of female RPT1Y260A, including
RPT area and number of cells per RPT (Figures 20A-C), excluding major histological defect as a
cause for the observed oliguria in females. Measurement of serum Li+ clearance, a marker for
RPT Na+ transport function, was significantly reduced in female RPT1Y260A mice confirming
the role of increased RPT Na+ absorption in the observed reduced natriuresis (Figures 20D-E).
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Figure 20: Female RPTα1Y260A mice exhibit increased RPT Na+ absorption.
(A-B) Average area and number of cells per proximal tubule per cross-section in female
RPTα1Y260A and RPTα1control. (C) Representative images from PAS-stained cross-sections of
kidney from female RPTα1Y260A compared to RPTα1control. (D-E) Serum lithium clearance curve
and quantification of area under curve (AUC) in female RPTα1Y260A and RPTα1control. Curve and
AUC normalized to peak dose in serum measured at 1hr (n=3-5, four month females). Results
are presented as mean ± SEM and data were analyzed by Student’s t-test. *p<0.05, ***p<0.001
vs female RPTα1control.
Regulation of NHE3 by NKA/Src in male and female
Apical NHE3 expression and trafficking is a major influencer of Na+ absorption by the
RPT. The expression and membrane localization of NHE3 contributes to the sex differences in
RPT Na+ absorption, with female rodents exhibiting decrease expression of membrane NHE3
and Na+ transport in the RPT, under basal conditions (Veiras et al., 2017). As NKA-mediated
tonic inhibition of RPT Na+ transport is dependent on the inhibition of NHE3 as confirmed by
RPT1-/-NHE3-/- mice (Figure 11), we determined the role of NHE3 in the sexual dimorphism
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observed in RPT1Y260A mice. Consistent with the sex-difference in the urinary phenotype, we
found more than 50% increase in the membrane abundance of NHE3 in female RPT1Y260A
compared to female RPT1WT as well as their controls, while there was no change in the males
(Figure 21).

Figure 21: Membrane abundance of NHE3 in Male and Female RPTα1Y260A. Representative
western blot and quantification of NHE3 in isolated membrane homogenates from renal cortex of
males (A-B, n=4) and females (C-D, n=4-5) RPTα1Y260A mice compared to their respective
controls. All quantifications were normalized to E-cadherin followed by normalization to the
average of male in each gel. Results are presented as mean ± SEM and data was analyzed by
one-way ANOVA with a Tukey multiple comparisons test. *p<0.05 vs RPTα1control.
Sexual dimorphism in phosphorylation of Y260 residue of NKA 1 in renal cortex
of C57Bl/6 mice under basal conditions.
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The Y260 residue of NKA 1 is a Src-specific phosphorylation and binding site and the
pY260 is a feature of Src regulation by NKA receptor (Banerjee et al., 2018). To assess whether
the sex-differences in RPTα1Y260A mice also indicate a difference in NKA/Src binding and
regulation at basal level, we determined the protein expression of pY260 NKA 1, total NKA
1, as well as NHE3 in the membrane protein isolated from the RPT-rich renal cortex of 16week male and female wild-type C57Bl/6 mice. We observed a threefold increase in the
expression of pY260 NKA 1 with no change in the total NKA 1 in females compared to
males, indicating a higher proportion of NKA 1 is phosphorylated and bound by Src and
engaged in the regulation of Src in females compared to males (Figures 22A-D). Simultaneously,
as reported in previous studies, we found a decrease in the membrane expression of NHE3 in
female compared to male mice under basal conditions (Figures 22A, 22E).
Collectively, this set of data indicates a sexual dimorphism in NKA/Src-mechanism of
inhibition of Na+ transport and NHE3 in the RPT of mice.
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Figure 22: C57Bl/6 female mice exhibit increased phosphorylation of Src-binding Y260
residue of NKA α1 under basal conditions.
Representative western blots (A) and quantification of pY260 NKA α1 (B), total NKA α1 (C),
the ratio of pY260 to total NKA α1 (D), and NHE3 (E) in isolated membrane homogenates from
renal cortex of male and female wild-type mice under basal condition. All quantifications were
normalized to E-cadherin followed by normalization to the average of male values in each gel.
Results are presented as mean ± SEM for n=4-5 and data was analyzed by Student’s t-test.
*p<0.05 vs male C57Bl/6 mice.
Discussion
An increasing number of studies report that the differences between sexes in physiology
extend beyond the reproductive system (Karp et al., 2017). Women have lower basal blood
pressure than men, have lower risk of developing hypertension, and are protected from
cardiovascular and renal disease relative to men (Mozaffarian et al., 2016; Song et al., 2020).
The wider prevalence of hypertension and cardiovascular diseases in men compared to women
has shed light on clear sex-dependent differences in physiological adaptations and tissue
regulation. Kidney structure and physiology exhibits notable sexual dimorphism in mice, rats,
and humans (R. Hu et al., 2020; Q. Li et al., 2018; Sabolić et al., 2007; Veiras et al., 2017).
Distinctive renal transporter expressions and their regulations between females and male nephron
underlie the physiological and potentially pathophysiological difference in renal Na+ handling
and blood pressure regulation. The female nephron exhibits lower dependence on renal proximal
tubule (RPT)-mediated bulk Na+ absorption and exhibit higher absorption in the distal tubule
compared to males that demonstrate a higher RPT-mediated absorption of Na+ (Veiras et al.,
2017). Investigations of molecular machineries involved in the regulation of RPT Na+ transport
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is of primordial importance to the development of targeted management of hypertension and
gender has an important role to play in these investigations.
In the present studies, we uncovered a remarkable sexual dimorphism in the natriuretic
NKA/Src-mechanism of tonic inhibition of NHE3 and RPT Na+ transport. Expression of Srcsignaling null mutant Y260A NKA 1 in RPT of mice presented a RPT-mediated hyperreabsorptive phenotype in females but not in males. The sex-difference in the urinary phenotype
of RPT1Y260A mice was supported by increased membrane abundance of NHE3 in female renal
cortex compared to both its control and female RPT1WT while in males there was no significant
change. This sex-dependent presentation proposes difference in dependence on NKA/Srcmediated inhibition of RPT Na+ transport as the regulatory mechanism contributing to the lower
Na+ absorption observed in female RPT compared to males in mice. The observed difference in
phenotype presentation is consistent with the increased basal levels of Src-mediated
phosphorylation of Y260 residue of NKA in females that may be an indicator of increased
dependence on NKA/Src signaling function. The increased NKA/Src dependence may contribute
to the reported increased inhibition of RPT NHE3 and Na+ transport in females. Collectively, this
study provides important evidence of sex-dependent difference in signaling mechanisms at the
molecular level to impact function not only at the cellular level but potentially at the systemic
level.
The lack of change in the RPT Na+ transport in male RPT1Y260A is a contrast to the
hyper-reabsorptive phenotype in male RPT1-/-. This may have several potential explanations
which require exploration. First, we examined if the dimorphism is an artifact of the genetic
model itself. However, as evidenced by comparable levels of downregulation in cortical pY260
and rescue of total NKA α1, we believe that to not be the case in these mice. Second, while
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compensation through sex-dependent compensatory modulation of alternate RPT and distal Na+
transporters could explain the unchanged natriuresis, we found that the membrane expression of
NHE3 was unchanged in the male RPTα1Y260A mice while it was increased in females. Thus, the
sexual dimorphism is upstream to NHE3 regulation. Third, in its non-enzymatic signaling
function, NKA α1 has been reported to interact and modulate a variety of crucial signaling
proteins. In LLCPK1 cells, pharmacological inhibition of either c-Src or PI3K exhibits a loss of
ouabain/NKA receptor-mediated inhibition of NKA and NHE3 (H. Cai et al., 2008). In RPT1-/mice, both male and female mice exhibit the decreased natriuresis and Na+ hyper-reabsorptive
phenotype (Figures 9-10). However, the loss of NKA receptor leads to loss of interaction with all
the protein interactions, including but not limited to, c-Src, PI3K, IP3R, PKC, caveolin-1, and
cytoskeletal proteins (T. Cai et al., 2008; Ying Chen et al., 2008; Tian et al., 2006; L. Zhang et
al., 2008). The contrast between male RPT1-/- and RPT1Y260A mice may also be a result of
sex-dependent compensatory activation of other signaling partners or a sex-bias in receptor
signaling. Sex-biased receptor signaling, wherein specific pathways engaged by ligand binding
are determined by sex, has been demonstrated by receptor systems including several G-protein
coupled receptors (Bangasser et al., 2010; Yagami, Tohkin, & Matsubara, 1990). NKA receptor
exhibits biased signaling on binding of structurally distinct CTS ligands (Xu et al., 2021) that by
affecting the conformation of NKA 1 influences the interaction of NKA with effector proteins,
however the role of gender and sex hormones on this is unknown. Future investigation on the
effect of Y260A mutation on the distribution of NKA and effector proteins in caveolar and noncaveolar fractions, and study of transgenic animals with mutations impacting NKA’s interaction
with other effector proteins, such as caveolin-1 or PI3K, in the RPT could be valuable to
unraveling the mechanism of NKA/Src sexual dimorphism. Fourth, sex hormones could
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influence NKA non-enzymatic inhibition of NHE3 and Na+ absorption in the RPT. Testosterone
upregulates NHE3 expression, potentially through the increased androgen receptor expression in
RPT, in male mice (Harris, Lee, Verlander, & Weiner, 2020). Progesterone inhibits binding of
ouabain to NKA 1 and ameliorates marinobufagenin (MBG)-induced collagen synthesis by
cardiac fibroblast in vitro but its interaction with NKA at the physiological level is poorly
understood (Drummond et al., 2013). RPT expresses both androgen and estrogen receptors to
levels consistent with the respective gender (Davidoff, Caffier, & Schiebler, 1980; Harris et al.,
2020; Takeda, Chodak, Mutchnik, Nakamoto, & Chang, 1990). Studies also report non-genomic
binding and action of sex hormones on plasma membrane protein and receptors in non-renal
tissues, including NKA (Farnsworth, 1970; Farnsworth, 1990; Nadal et al., 2000). There is a
possibility for cross-talk between NKA receptor, sex hormone receptors and their respective
ligands that collectively influence NKA’s natriuretic function in the RPT. Thus, there are several
possible explanations that on further exploration may help uncover the underlying cause of the
observed sexual dimorphism in NKA/Src-mechanism of inhibition of NHE3 and Na+ absorption
in RPT.
In conclusion, this study highlights the importance of improving our understanding of the
natriuretic mechanism of NKA signaling in the RPT and its potential impact on sex-based
differences in renal physiology and potentially pathophysiology such as in the development saltsensitive hypertension.
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CHAPTER 4
DISCUSSION AND CONCLUSIONS
Functionally dominant natriuretic signaling through NKA 1 in RPT Na+ transport
These studies revealed several new facets of NKA in RPT Na+ transport. In the RPTspecific NKA 1 hypomorphic mouse model, we observed a significant increase in RPT Na+
absorption with no change in GFR and decreased natriuresis and diuresis. This phenotype of
increased RPT Na+ absorption goes against expectations based solely on the loss of the classical
NKA enzymatic activity, which would be expected to decrease RPT Na+ reabsorption or result in
mild or no change. Indeed, only 20-30% NKA is sufficient to support basal Na+ reabsorption
function (Cheval & Doucet, 1990). Although compensatory mechanisms of sodium transport in
the paracellular pathway or distal segments may take place, they would be expected to restore
homeostasis but not to increase sodium absorption above the controls. Thus, this remarkable
phenotype reveals a critical physiological function of NKA as a non-enzymatic receptor in tonic
inhibition of RPT Na+ reabsorption.
Further, the non-enzymatic signaling-mediated natriuretic function of NKA 1 is not
only physiologically relevant, but also functionally dominant over its anti-natriuretic enzymatic
function. While the enzymatic function is indeed vital for cell survival and potentially plays a
role in anti-natriuresis and balancing the natriuretic regulatory function, the classical ion-pump is
not the dominant role of NKA 1 in the RPT. This non-enzymatic (i.e. signaling-mediated)
inhibitory role for 1 in Na+ transport regulation has been previously proposed in studies using
different models, such as in vitro in LLC-PK1 cells treated with ouabain (H. Cai et al., 2008),
mouse kidneys treated with CTS, and in the polygenic Dahl salt-sensitive rats (Liu et al., 2011).
These studies while vital to our understanding of the pro-natriuretic regulation by NKA, did not
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provide direct genetic, physiological, and tissue-specific evidence of the NKA non-enzymatic
function. Therefore, this is the first genetic demonstration of a direct physiological relationship
between NKA 1 and inhibition of RPT Na+ transport.
Subsequently, the next step is to address the physiological importance of endogenous
CTS as ligands to the NKA pro-natriuretic function in the RPT. We can utilize the established
tissue-specific genetic rescue approach to achieve RPT-specific replacement of CTS-resistant α1
by CTS-sensitive WT or signaling-mutant α1 in mouse.
NKA 1 non-enzymatic regulation of NHE3 and NBCe1A.
In the hypomorphic RPT1-/-, the hyper-reabsorptive phenotype was accompanied by a
decreased phosphorylation-mediated inactivation of NHE3 and its increased membrane
expression, along with increased membrane abundance of basolateral NBCe1A (Figure 11). The
importance of loss of NKA-mediated regulation of NHE3 in the observed hyper-reabsorption in
RPT1-/- was confirmed when ablation of NHE3 in the RPT1-/- generated RPT-specific NKA
1 and NHE3 double hypomorphic mice (RPT1-/-NHE3-/-) that restored urine and sodium
output to values comparable to controls (Figure 11).
Na+ transport and Acid-base balance by RPT
The inter-dependent regulation of NKA, NHE3 and NBCe1A potentially has implications
in the uncoupling necessary for the RPT to carry out the reabsorption of bicarbonate and the
secretion of acid. The uncoupling can be vital to establish acid-base balance in response to the
acidic western diet without compromising the pressure and volume homeostasis. Previously, pH
sensors have been postulated to stimulate the coupled changes in expression of NHE3 and
NBCe1A. An early investigation supported a basolateral sensor in this response (L. K. Chen &
Boron, 1995). While there have been reports of distinct molecular pathways in this mechanism,
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activation of non-receptor tyrosine kinases Pyk2 followed by c-Src stimulates both NHE3 and
NBCe1A in response to decreased intracellular pH (Espiritu, Bernardo, Robey, & Arruda, 2002;
Preisig, 2007). Dahl salt-sensitive rats exhibit increased renal acid excretion and decreased
intracellular pH which are hallmarks of development of metabolic acidosis (Batlle et al., 1993).
The RPT cells from these salt-sensitive rats also demonstrate impaired CTS-activated NKA 1
inhibition of NHE3 which supports the increased RPT Na+ absorption and blood pressure in
these rats (Liu et al., 2011). The nuances of NKA 1-mediated interdependent inhibitory
mechanism and its potential influence on the cellular response to intracellular pH require further
investigations.
Molecular mechanism of NKA natriuretic function in RPT
Our findings in renal epithelial cells with loss of Src-binding NKA 1 mutation as well
as the gain of Src-binding NKA 2 mutation indicated NKA/Src interaction is not only
necessary for the phosphorylation-mediated inactivation of NHE3 but also inhibition of
increased total expression of NBCe1A (Figure 14). To our knowledge, this is the first description
of a Src-mediated mechanism that links NKA, NHE3, and NBCe1A in an interdependent
pathway. This is a notable finding as the previously recognized regulatory pathways of RPT Na+
handling such as PKA, PI3K, PKC play a role in the coordinated and parallel, but independent
regulation of NHE3 and NBCe1A, and NKA (M. C. Hu et al., 2001; Kocinsky et al., 2007;
Kurashima et al., 1997; Riquier-Brison, Leong, Pihakaski-Maunsbach, & McDonough, 2009).
The downstream signaling molecules involved in the NKA receptor mediated
phosphorylation of (Ser-552)-NHE3 and subsequent decreased membrane abundance are yet
unknown. The phosphorylation at ser552 of NHE3 is an established mechanism of inhibition by
dopamine and in that pathway it involves activation of cAMP-PKA pathway (Kocinsky et al.,
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2007; Kurashima et al., 1997). While c-Src, a non-receptor tyrosine kinase, does not directly
phosphorylate a serine residue, it could activate intermediate signaling molecules to activate
PKA via cAMP-dependent or independent mechanisms in vitro and in vivo. The cAMPindependent activation of PKA involves activation of endothelin-1 (Dulin, Niu, Browning,
Richard, & Voyno-Yasenetskaya, 2001), a factor also indicated to activate NHE3 and NBCe1A,
stimulated by Pyk2/c-Src pathway (Curthoys & Moe, 2014; Espiritu et al., 2002; Preisig, 2007).
As part of our future studies, we can test the relevance of these signaling molecules in the
NKA/Src regulation by utilizing in vitro genetic silencing approaches or specific inhibitors of
cAMP and PKA to study its impact on basal and CTS-activated inhibition by NKA of NHE3.
Another factor proposed to play a role in the NKA/Src mechanism is reactive oxygen
species (ROS). NKA/Src signaling activates ROS which in turn through direct carbonylation
modification of Pro224 on NKA 1 activates NKA signal transduction (Y. Wang et al., 2014;
Yan et al., 2013; Yan, Shapiro, Mopidevi, Chaudhry, Maxwell, Haller, Drummond, Kennedy,
Tian, & Malhotra, 2016). Superoxide generated by NADPH-oxidase inhibits NHE3 in adult
spontaneously hypertensive rats (Panico et al., 2009). Thus, physiological concentration of ROS
could not only activate NKA signaling but also play an intermediary role in the signaling
transduction in vitro and in vivo (Yan, Shapiro, Mopidevi, Chaudhry, Maxwell, Haller,
Drummond, Kennedy, Tian, & Malhotra, 2016).
A third potential mechanism of modulation of NHE3 by NKA signaling is more relevant
to our findings in vivo than in vitro. Intracellular [Na+], through interaction with a yet to be
established salt-sensing protein, modulates the sensitization or desensitization of molecular
pathways that facilitate receptor recruitment of dopamine and angiotensin-II in RPT (Efendiev et
al., 2003). Both dopamine and angiotensin-II are important hormonal regulators of natriuresis
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and blood pressure through its action on RPT NHE3 and Na+ absorption. NKA/Src signaling can
also be activated by increased intracellular [Na+] in renal epithelial cells (Ye et al., 2011). As
reported previously (H. Cai et al., 2008) and shown in figure 14, the same NKA/Src signaling
mechanism inhibits NHE3 and Na+ transport. In human embryonic kidney cells (HEK293T),
NKA forms a complex with D1 and D2 dopamine receptor and exhibits reciprocal regulation that
influences dopamine receptor expression (Hazelwood, Free, Cabrera, Skinbjerg, & Sibley, 2008).
While the findings in the RPT1-/- mouse establish NKA as a potent tonic inhibitory mechanism
of Na+ transport, they could also be an indicator of a master-regulator role for NKA as the long
sought after salt-sensor. To test the role as a salt-sensor, future experiments need to be designed
to study the impact of [Na+] on NKA’s pro-natriuretic function in RPT and the impact of
signaling mutants on this interaction in vitro and in vivo.
Finally, as NKA receptor interacts with multiple proteins, we cannot discount the role of
interaction with other signaling proteins in this regulatory mechanism by NKA 1 in vivo.
Indeed, when Src-signaling null Y260A NKA 1 mutant is expressed in RPT of mouse, we see a
loss of NKA-mediated regulation of Na+ transport in females but not in males (Figure 20). This
could indicate to a role for other signaling proteins that potentially compensates for absence of
Src-mediated regulation or play a more predominant role in the NKA-mediated regulation in
males.
Sexual Dimorphism in NKA/Src-mediated inhibition of RPT Na+ absorption.
Sexual dimorphic variations are present in many aspects of biology and involve the
structure and function of nearly every organ system in the mammalian body. Numerous studies
have reported critical distinctions between male and female renal physiology which translates to
the differences in risk of development and the severity of hypertension between men and women,
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mainly premenopausal women (Mozaffarian et al., 2016; Song et al., 2020). In rats and mice, the
most commonly used animal models for studies on renal physiology, females show decreased
sodium transport in the RPT and an increased sodium transport in distal tubule compared to
males. Consistently, in females, the expression of key Na+ transporters in the RPT are reduced in
total expression and/or reduced in their membrane localization while the transporter expression
in the distal tubules is increased compared to males (Q. Li et al., 2018; Veiras et al., 2017). The
physiological differences translate to females being less dependent on RPT for absorption of
almost two-third of filtered Na+ and an increased dependence on distal tubule improves the
ability to adapt to systemic challenges, which include pregnancy, child birth, and breast-feeding
(West, Sasser, & Baylis, 2016). Distinct transporter expression or its membrane abundance could
be an indication of differences in mechanism of their regulation. NHE3, the major apical RPT
Na+ transporter, has a reduced membrane localization in females. Since NKA 1 mediated tonic
inhibition of NHE3 is a potent mechanism of natriuretic regulation, differences in ligandreceptor-effector interactions could underlie the sex-based difference of NHE3.
In vitro studies in renal epithelial cells indicate Src to be a mediator in the NKA
inhibition of NHE3 and NBCe1A. To test the relevance of this finding in physiology, we
generated mice with RPT-specific hypomorphic endogenous NKA 1 and rescue of expression
with exogenous WT or Src-signaling mutant NKA 1. In mice expressing the Src-signaling null
Y260A mutant in their RPT, female mice exhibited hyper-reabsorption of Na+ by their RPT due
to a disrupted NKA/Src signaling while male mice showed no change in their daily urine and
sodium output (Figure 20). Notably, female mice show increased phosphorylation of Y260
residue of NKA 1 that indicates an increased NKA/Src interaction and activity (Figure 22). The
lack of change in male could be an indicator of sex-bias in signaling mechanism of NKA-
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mediated inhibition of NHE3. NKA receptor interacts with multiple effector proteins that in turn
activate a variety of downstream signaling pathways. Structurally distinct CTS on binding to
NKA can influence the NKA/effector protein interaction leading to biased signaling. Further
studies are needed to fully delineated the mechanisms underlying the sexual dimorphism in
observed urinary phenotype of RPT1Y260A mice.
While, we specifically investigated NHE3 and Na+ absorption in this study, the sexual
dimorphism in mechanism of NKA signaling could extend to RPT absorption of Na+ via other
RPT transporters and to absorption of other solutes through transcellular and paracellular
pathways. RPT plays a crucial role in acid-base balance and in that ammonia metabolism is
crucial to the net acid excretion. Renal ammonia metabolism is sexually dimorphic in mice and
while the male and female mice generate a similar maximal ammonia excretion in response to an
acid load, they use sex-specific pathways to achieve this response (Harris, Lee, Fang, Verlander,
& Weiner, 2019). NKA non-enzymatic receptor regulates NBCe1A however the role of gender
in this regulation is yet to be investigated.
Another important transporter with clinical importance in the RPT is the SGLT2 that
primarily reabsorbs most of glucose filtered into the kidney. In rats, females exhibit higher
SGLT2 expression and activity than males but whether these differences extend to humans is still
unclear (Shepard, 2019). Interestingly, SGLT2 inhibitors (a drug of choice for treatment of typeII diabetes) exhibits greater adverse effects in females compared to male but the prevalence of
type-II diabetes is higher in males compared to females (Kautzky-Willer & Harreiter, 2017). We
observed a significant decrease in urinary glucose excretion in RPT1-/- in males and females,
however we cannot rule out sex-bias at the regulatory level like the bias in regulation of NHE3
and Na+ transport in RPT1Y260A mice.
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Clinical implications.
Numerous preclinical and clinical studies have found association between endogenous
CTS and changes in blood pressure in health and disease, but the study of the underlying
mechanism of action has been fraught with challenges including the ubiquitous nature of its
receptor NKA 1.The RPT NKA non-enzymatic regulatory mechanism uncovered by this
genetic approach provides a long sought-after receptor mechanism to explain the natriuretic
effect of endogenous CTS, which has first been proposed more than 50 years ago. With a wide
prevalence of over a billion people globally affected by hypertension, half of which are
considered as salt-sensitive hypertension, resolving the pathophysiological causes underlying this
largely idiopathic disorder is the need of the hour. The identification of NKA as a regulator of
Na+ transport in RPT could pave the way for the development of novel treatments for saltsensitive hypertension which target the NKA signaling axis, or revisiting targeted delivery of
existing CTS drugs such as ouabain or digoxin that are capable of activating NKA signaling axis
and thereby stimulating natriuresis.
Interestingly, in a clinical study in members of Framingham heart study, heterozygous
and rare mutations in SLC12A3, SLC12A1, and KCNJ1 were shown to produce significant
blood pressure reduction and protect participants from development of hypertension (Ji et al.,
2008). These findings implicate other rare yet undiscovered alleles and variations in the
prevention or development of hypertension. In light of the discovery of a functionally dominant
pro-natriuretic role of NKA signaling, we should renew our investigations into variants of NKA
1 that may have protective effects or be associated with increased risk of hypertension.
The two transporters demonstrated to be inhibited by NKA 1-NHE3 and NBCe1A- also
have functional importance in RPT-mediated acid-base balance by absorption of bicarbonate and
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excretion of acid. Over the last few decades, investigations including genetic based studies have
proposed that changes in the expression and function of the acid-base transporters can be
involved in blood pressure dysregulation (Boedtkjer et al., 2011; Ehret et al., 2011; Luft, Zemel,
Sowers, Fineberg, & Weinberger, 1990). There is reportedly an association between saltsensitive hypertension and acidosis and salt-sensitive hypertensive animal models with acidosis
observe acidemia before the onset of hypertension (Batlle et al., 1993; Lucas, Lacour, McCarron,
& Drüeke, 1987). However, the underlying mechanism linking disturbed acid-base transport
activity to hypertension is not clearly understood, partly due to gaps in our understanding of
regulatory mechanisms involved in uncoupling of Na transport from acid-base transport in
healthy physiology. With NKA signaling demonstrating an interdependent regulation of NKA,
NHE3 and NBCe1A, it may hold clues to unraveling salt-sensing, pH sensing, and the
mechanistic pathways balancing the two functions.
In RPT1-/-, we also observed a decrease in glucose urinary excretion with no basal
change in glucose and insulin tolerance which fits with systemic compensation in unchallenged
conditions (Table 4, Figure 10). SGLT2, expressed in the RPT, is the primary glucose transporter
in absorption of glucose in a Na+-dependent manner in the kidney and SGLT2 inhibitors are used
to treat type-II diabetes and are associated with reno-protective effects and decreased
cardiovascular comorbidities (Wanner & Marx, 2018). However, the mechanism and regulation
underlying these benefits are unclear. Thus, there is need to understanding the role and regulation
of SGLT2 in metabolic and cardiovascular disorders. Since loss of RPT NKA receptor is
associated with an increase in renal glucose absorption, NKA receptor in RPT should be
investigated for its role in renal and systemic glucose homeostasis.
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The findings in these studies could also improve our understanding of underlying
mechanisms of conditions exhibiting overall defective RPT absorption like Fanconi syndrome. In
the acquired Fanconi syndrome, an adult can develop the condition due to wide variety of
reasons from consumption of chemotherapeutic agents like antivirals, to exposure to toxins, like
lead poisoning, or even a honeybee sting (Keefe & Bokhari, 2020). There is no known cure and
current treatment regimens are mainly limited to replacement of lost electrolytes and avoidance
of dehydration. With RPT transport of all electrolytes primarily dependent on Na+ transport, one
can speculate on the primary and secondary effects of NKA-mediated regulations on the
transport of all electrolytes by RPT and its potential therapeutic potential.
Finally, identification of a higher dependence on NKA/Src-mediated inhibition in
females compared to males and a potential sex-bias in the regulation underscores the importance
of studying sex-based differences in molecular physiologies. The identification of such
distinctions could prove useful in improving sex-based targeted therapies with improved efficacy
and minimized adverse effects.
Future studies
We have only begun to unravel the importance and mechanism of NKA-mediated
regulation of Na+ absorption by RPT. We have not investigated the impact of NKA ablation or
expression of mutant NKA on other RPT transporters such as SGLT2 and Na+/Pi cotransporter
(NaPi2) which may also be regulated by the NKA receptor. Specific molecular mechanisms
involved in NKA/Src mediated inhibition of NHE3 and NBCe1A in female and alternate
molecular mechanism involved in NKA-mediated inhibition in males are yet to be defined. We
also need to investigate the importance of this regulation in the modulation of blood pressure and
in adaptation to changes in systemic sodium.
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APPENDIX B
ABBREVIATIONS
µg – micrograms; 1/1000000th of a gram
µL – microliter; 1/1000000th of a liter
µM – micromolar; 1/1000000th of a molar
µm – micrometer; 1/1000000th of a meter
AAC-19 – porcine renal epithelial cell line
ACTH – adrenocorticotrophic hormone
ADP – adenosine diphosphate
Akt – protein kinase B (see also: PKB)
ANOVA – analysis of variance
ANP – atrial natriuretic peptide
Aqp-1 – Aquaporin-1
AT1 receptor – receptor for angiotensin-II
ATCC – American Type Culture Collection
ATP – adenosine triphosphate
ATP1A1 – gene for Na/K-ATPase α1
AUC – area under the curve
BP – blood pressure
BUN – blood urea nitrogen
BW – body weight
Ca2+ – calcium
cAMP – cyclic adenosine monophosphate
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cav-1 – caveolin-1
CD2 – second cytoplasmic domain
CD3 – third cytoplasmic domain
Cl- – chloride
CSA – cross-sectional area
CTS – cardiotonic steroids
D1 receptor – subtype of dopamine receptor
D2 receptor – subtype of dopamine receptor
dL – deciliter; 1/100th of a liter
DMEM – Dulbecco’s modified Eagle’s medium
EBC – exhaled breath condensate
ECL – enhanced chemiluminescence
EDTA – ethylenediaminetetraacetic acid
EGF – epidermal growth factor
EIA – enzyme immunoassay
EO – endogenous ouabain
ERK – extracellular regulated kinase
EVOM2 – epithelial volt ohm meter-2
FBS – fetal bovine serum
FIJI – FIJI is just ImageJ
FITC – fluorescein isothiocyanate
FXYD2 – gamma
g – gram
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g/dL – gram/deciliter
GFR – glomerular filtration rate
GTB – glomerulotubular balance
GTT – glucose tolerance test
h – hour
H+ – proton
HCO3- – bicarbonate
H&E – hematoxylin and eosin
HK2 – human kidney cells
H2O – water
H2O2 – hydrogen peroxide
IP – intraperitoneal
IP3 – inositol 1,4,5-triphosphate
ITT – insulin tolerance test
I.V. – intra-venous
JDEX – flux of neutral 3 kilodalton dextran
K+ – potassium
kDa – kilodalton
LAS/AF – Leica Application Suite/Advanced Fluorescence
Li+ – lithium
LiCl – lithium chloride
LX-α2 – LLC-PK1-derived cell line
LY-a2 – LLC-PK1-derived cell line

139

M– molar
mL – milliliter
MBG – marinobufagenin
MBS – MES-buffered saline
MDCK – Madin-Darby canine kidney cells
MEK – mitogen activated protein kinase kinase
MES – 2-(N-Morpholino)ethanesulfonic acid
Mg2+ – magnesium
mEq/L – milliequivalent/liter
mg/dL – milligram/deciliter
mg/g – milligram/gram
mg/kg – milligram/kilogram
MIIR – Marshall Institute for Interdisciplinary Research
min – minutes
mmHg – millimeters of Mercury
mM – millimolar; millimoles per liter (see also: mmol)
mRNA – messenger ribonucleic acid
Na/K-ATPase – sodium-potassium adenosine triphosphatase (see also: NKA)
Na+ – sodium
22Na+

– radioactive sodium

NaCl – sodium chloride
NADPH – reduced form of nicotinamide adenine dinucleotide phosphate
NaPi2a – sodium-phosphate cotransporter-2a
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NaSi-1 – sodium-sulfate cotransporter-1
NBCe1A – sodium-bicarbonate cotransporter-1A
NC – normal chow
NCC – sodium-chloride cotransporter
NFkB – nuclear factor kappa B
NHE3 – sodium-proton exchanger-3
NIH – National Institute of Health
NKA – sodium-potassium adenosine triphosphatase (see also: Na/K-ATPase)
NKCC2 – sodium-potassium-chloride cotransporter-2
nm – nanometer
NO – nitric oxide
OD – optical density
OK – opposum kidney cells
PAS – periodic acid schiff
PBS – phosphate-buffered saline
PCR – polymerase chain reaction
pg – picogram
PI3K – phosphoinositide 3-kinase
PKA – protein kinase A
PKC – protein kinase C
PMSF – phenylmethylsulfonyl fluoride
PNx – partial nephrectomy
PO43- – phosphate
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Pro – proline residue
pS552 – phosphorylation at serine residue 552
PTEC – proximal tubule epithelial cells
PTH – parathyroid hormome
PVDF – polyvinylidene difluoride
PY-17 – LLC-PK1-derived cell line
pY260 – phosphorylation at tyrosine-260 residue
Pyk2 – non-receptor protein tyrosine kinase-2
RIHP – renal interstitial hydrostatic pressure
RIPA – radioimmunoprecipitation assay
RNA – ribonucleic acid
ROI – region of interest
ROS – reactive oxygen species
rpm – rotations per minute
RPT – renal proximal tubule
RPT1-/- – renal proximal tubule-specific NKA 1 hypormorphic mouse
RPT1+/+– renal proximal tubule -specific NKA 1 expressing mouse; control to RPT1-/RPT1control– renal proximal tubule -specific NKA 1 expressing mouse; control to rescue
mouse
RPT1-/-NHE3-/-– renal proximal tubule -specific NKA 1 and NHE3 hypomorphic mouse
RPT1+/+NHE3+/+– renal proximal tubule -specific NKA 1 expressing mouse; control to
RPT1-/-NHE3-/RPT1WT– renal proximal tubule -specific wild-type NKA 1 rescue mouse
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RPT1Y260A– renal proximal tubule -specific Src-binding mutant Y260A NKA 1 rescue mouse
RT – reverse transcriptase
RT-PCR – real-time polymerase chain reaction (see also: qPCR, qRT-PCR)
SDS-PAGE – sodium dodecyl sulfate–polyacrylamide gel electrophoresis
SEM – standard error of the mean
Ser – serine residue
SGLT-2 – sodium-glucose cotransporter-2
siRNA – small-interfering ribonucleic acid
SO42- – sulfate
Src – proto-oncogene tyrosine-protein kinase Src (see also: c-Src)
TBST – Tris-buffered saline
TCG – telecinobufagenin
TER – transepithelial electrical resistance
TGF – tubuloglomerular feedback
TJ – tight junction
Tris-HCl – tris(hydroxymethyl)aminomethane hydrochloride
Tyr – tyrosine residue
UNaV – Absolute sodium output
Vmax – maximum velocity of enzyme reaction
WT – wild-type
xg – times gravitational force
Y260A – LLC-PK1 derived cell line
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